Immunogenic cell stress and death in the treatment of cancer

The successful treatment of oncological malignancies which results in long-term disease control or the complete eradication of cancerous cells necessitates the onset of adaptive immune responses targeting tumor-specific antigens. Such desirable anticancer immunity can be triggered via the induction...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Seminars in cell & developmental biology Jg. 156; S. 11 - 21
Hauptverfasser: Pan, Hui, Liu, Peng, Zhao, Liwei, Pan, Yuhong, Mao, Misha, Kroemer, Guido, Kepp, Oliver
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Elsevier Ltd 15.03.2024
Elsevier
Schlagworte:
Antigens, Neoplasm
Antineoplastic Agents - pharmacology
Cell Death
Humans
Life Sciences
Neoplasms - pathology
T-Lymphocytes
ICD
APC
ICI
DAMP
DC
dendritic cells ICD
immune checkpoint inhibitor
immunogenic cell death
antigen presenting cell DAMP
damage associated molecular pattern DC
dendritic cells
damage associated molecular pattern
antigen presenting cell
immunogenic cell death ICI
ISSN:1084-9521, 1096-3634, 1096-3634
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The successful treatment of oncological malignancies which results in long-term disease control or the complete eradication of cancerous cells necessitates the onset of adaptive immune responses targeting tumor-specific antigens. Such desirable anticancer immunity can be triggered via the induction of immunogenic cell death (ICD) of cancer cells, thus converting malignant cells into an in situ vaccine that elicits T cell mediated adaptive immune responses and establishes durable immunological memory. The exploration of ICD for cancer treatment has been subject to extensive research. However, functional heterogeneity among ICD activating therapies in many cases requires specific co-medications to achieve full-blown efficacy. Here, we described the hallmarks of ICD and classify ICD activators into three distinct functional categories namely, according to their mode of action: (i) ICD inducers, which increase the immunogenicity of malignant cells, (ii) ICD sensitizers, which prime cellular circuitries for ICD induction by conventional cytotoxic agents, and (iii) ICD enhancers, which improve the perception of ICD signals by antigen presenting dendritic cells. Altogether, ICD induction, sensitization and enhancement offer the possibility to convert well-established conventional anticancer therapies into immunotherapeutic approaches that activate T cell-mediated anticancer immunity.
AbstractList The successful treatment of oncological malignancies which results in long-term disease control or the complete eradication of cancerous cells necessitates the onset of adaptive immune responses targeting tumor-specific antigens. Such desirable anticancer immunity can be triggered via the induction of immunogenic cell death (ICD) of cancer cells, thus converting malignant cells into an in situ vaccine that elicits T cell mediated adaptive immune responses and establishes durable immunological memory. The exploration of ICD for cancer treatment has been subject to extensive research. However, functional heterogeneity among ICD activating therapies in many cases requires specific co-medications to achieve full-blown efficacy. Here, we described the hallmarks of ICD and classify ICD activators into three distinct functional categories namely, according to their mode of action: (i) ICD inducers, which increase the immunogenicity of malignant cells, (ii) ICD sensitizers, which prime cellular circuitries for ICD induction by conventional cytotoxic agents, and (iii) ICD enhancers, which improve the perception of ICD signals by antigen presenting dendritic cells. Altogether, ICD induction, sensitization and enhancement offer the possibility to convert well-established conventional anticancer therapies into immunotherapeutic approaches that activate T cell-mediated anticancer immunity.The successful treatment of oncological malignancies which results in long-term disease control or the complete eradication of cancerous cells necessitates the onset of adaptive immune responses targeting tumor-specific antigens. Such desirable anticancer immunity can be triggered via the induction of immunogenic cell death (ICD) of cancer cells, thus converting malignant cells into an in situ vaccine that elicits T cell mediated adaptive immune responses and establishes durable immunological memory. The exploration of ICD for cancer treatment has been subject to extensive research. However, functional heterogeneity among ICD activating therapies in many cases requires specific co-medications to achieve full-blown efficacy. Here, we described the hallmarks of ICD and classify ICD activators into three distinct functional categories namely, according to their mode of action: (i) ICD inducers, which increase the immunogenicity of malignant cells, (ii) ICD sensitizers, which prime cellular circuitries for ICD induction by conventional cytotoxic agents, and (iii) ICD enhancers, which improve the perception of ICD signals by antigen presenting dendritic cells. Altogether, ICD induction, sensitization and enhancement offer the possibility to convert well-established conventional anticancer therapies into immunotherapeutic approaches that activate T cell-mediated anticancer immunity.
The successful treatment of oncological malignancies which results in long-term disease control or the complete eradication of cancerous cells necessitates the onset of adaptive immune responses targeting tumor-specific antigens. Such desirable anticancer immunity can be triggered via the induction of immunogenic cell death (ICD) of cancer cells, thus converting malignant cells into an in situ vaccine that elicits T cell mediated adaptive immune responses and establishes durable immunological memory. The exploration of ICD for cancer treatment has been subject to extensive research. However, functional heterogeneity among ICD activating therapies in many cases requires specific co-medications to achieve full-blown efficacy. Here, we described the hallmarks of ICD and classify ICD activators into three distinct functional categories namely, according to their mode of action: (i) ICD inducers, which increase the immunogenicity of malignant cells, (ii) ICD sensitizers, which prime cellular circuitries for ICD induction by conventional cytotoxic agents, and (iii) ICD enhancers, which improve the perception of ICD signals by antigen presenting dendritic cells. Altogether, ICD induction, sensitization and enhancement offer the possibility to convert well-established conventional anticancer therapies into immunotherapeutic approaches that activate T cell-mediated anticancer immunity.
Author Pan, Hui
Kepp, Oliver
Pan, Yuhong
Mao, Misha
Zhao, Liwei
Liu, Peng
Kroemer, Guido
Author_xml – sequence: 1
  givenname: Hui
  surname: Pan
  fullname: Pan, Hui
  organization: Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France
– sequence: 2
  givenname: Peng
  surname: Liu
  fullname: Liu, Peng
  organization: Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France
– sequence: 3
  givenname: Liwei
  surname: Zhao
  fullname: Zhao, Liwei
  organization: Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France
– sequence: 4
  givenname: Yuhong
  surname: Pan
  fullname: Pan, Yuhong
  organization: Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France
– sequence: 5
  givenname: Misha
  surname: Mao
  fullname: Mao, Misha
  organization: Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France
– sequence: 6
  givenname: Guido
  surname: Kroemer
  fullname: Kroemer, Guido
  email: kroemer@orange.fr
  organization: Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France
– sequence: 7
  givenname: Oliver
  orcidid: 0000-0002-6081-9558
  surname: Kepp
  fullname: Kepp, Oliver
  email: captain.olsen@gmail.com
  organization: Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37977108$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04601413$$DView record in HAL
BookMark eNqFkU1r3DAYhEVJyVfzD0rxsT14q29ZpQRCaJrAQi_tWcjy664WW0olbSD_PjJOc-ghPUmMnhnQzBk6CjEAQu8J3hBM5Of9JsPshn5DMWVV2mCs3qBTgrVsmWT8aLl3vNWCkhN0lvMeY8w1lcfohCmtVH09RV_v5vkQ4m8I3jUOpqnJJUHOjQ1DM4Atu8aHpuygqbItM4TSxLFxNjhI79Db0U4ZLp7Pc_Tr5tvP69t2--P73fXVtnWc09KqbiSiHy1QUB2xTBAlqRSYcsKdkKLrOWM9c9qJkXYwWiuIlnTgTHNLlWXn6NOau7OTuU9-tunRROvN7dXWLBrmEhNO2AOp7MeVvU_xzwFyMbPPy8dsgHjIhnaaKKEp4xX98Iwe-hmGl-S_7VSAr4BLMecE4wtCsFlGMHuzjmCWERa1jlBtX_6xOV9s8TGUZP30P_PlaoZa6IOHZLLzUNsefAJXzBD96wFPJHOhcw
CitedBy_id crossref_primary_10_1016_j_jep_2024_118955
crossref_primary_10_1186_s12951_025_03255_8
crossref_primary_10_1080_2162402X_2024_2432059
crossref_primary_10_1016_j_semcdb_2023_11_004
crossref_primary_10_3390_cancers17122020
crossref_primary_10_1111_cas_16427
crossref_primary_10_1080_21645515_2024_2437918
crossref_primary_10_1016_j_jcis_2025_138144
crossref_primary_10_2147_IJN_S526305
crossref_primary_10_1016_j_snr_2025_100316
crossref_primary_10_3389_fphar_2024_1451067
crossref_primary_10_1016_j_canlet_2024_217079
crossref_primary_10_22465_juo_255000300015
crossref_primary_10_1016_j_canlet_2024_216695
crossref_primary_10_1007_s13346_025_01873_1
crossref_primary_10_1136_jitc_2024_010714
crossref_primary_10_1002_sstr_202500452
crossref_primary_10_1080_2162402X_2025_2514050
Cites_doi 10.1080/2162402X.2015.1008866
10.1111/cas.13885
10.1038/emboj.2009.1
10.1136/jitc-2020-001369
10.1080/2162402X.2018.1431086
10.1002/mc.22811
10.1080/2162402X.2023.2174723
10.3389/fonc.2019.00436
10.1080/2162402X.2023.2242211
10.1080/01635581.2021.1897632
10.1038/cdd.2008.67
10.1038/s41571-019-0272-7
10.3390/cancers12051314
10.1038/onc.2016.104
10.1021/acsnano.2c01669
10.3390/pharmaceutics14010196
10.1080/2162402X.2017.1338236
10.1038/s41419-021-03605-y
10.1016/j.xphs.2022.06.005
10.1111/bjh.12427
10.1126/science.1208347
10.3390/toxins10110470
10.1158/2326-6066.CIR-19-0616
10.3892/etm.2016.3368
10.1016/j.eclinm.2022.101430
10.1080/2162402X.2023.2219591
10.1158/2643-3230.BCD-21-0059
10.1186/s12943-015-0435-9
10.1182/blood-2016-08-731737
10.1016/j.semcancer.2015.02.004
10.1038/s41598-021-86239-6
10.4161/onci.28473
10.1016/j.redox.2022.102351
10.3389/fimmu.2022.941757
10.7150/thno.69168
10.1080/2162402X.2021.1996686
10.1016/j.celrep.2016.03.037
10.18632/oncotarget.4911
10.1080/2162402X.2021.1973197
10.1080/2162402X.2021.1962592
10.1080/2162402X.2023.2271693
10.1080/15548627.2016.1214778
10.1038/s41419-018-1127-3
10.1016/j.jid.2019.12.039
10.7150/ijbs.70975
10.1016/j.trecan.2020.12.012
10.1007/s00280-020-04209-7
10.1038/sj.cdd.4402269
10.1136/jitc-2021-004151
10.1038/cddis.2016.47
10.1038/nri2545
10.1016/j.ccell.2016.05.016
10.1021/acsnano.2c08013
10.1038/s41419-020-03226-x
10.1007/s00262-023-03470-y
10.1038/s41590-020-0751-0
10.1080/2162402X.2016.1149673
10.1158/1535-7163.MCT-21-0035
10.1038/s41467-020-19970-9
10.1080/2162402X.2022.2098658
10.1158/2159-8290.CD-22-1338
10.1007/s10637-013-9984-1
10.1080/2162402X.2019.1596652
10.1002/smtd.202300347
10.1016/S1470-2045(20)30068-1
10.1016/bs.mcb.2021.12.028
10.1080/23723556.2020.1776570
10.2147/IJN.S408855
10.1016/j.ccell.2023.04.015
10.1080/2162402X.2020.1862949
10.1038/s41580-023-00623-w
10.1016/j.redox.2021.101949
10.1038/onc.2009.356
10.1002/cmdc.202100656
10.1021/acsbiomaterials.2c00171
10.1002/smll.202300859
10.1038/nm1622
10.1084/jem.20050915
10.1080/2162402X.2019.1606665
10.1182/blood-2006-10-054221
10.1038/s41598-022-19597-4
10.3390/cancers13081954
10.15252/embj.201798354
10.4049/jimmunol.1701021
10.1080/2162402X.2022.2127273
10.1016/j.biomaterials.2021.121167
10.1016/j.cell.2023.03.006
10.1080/2162402X.2019.1594555
10.1080/2162402X.2016.1177692
10.1038/s41467-021-23752-2
10.1080/2162402X.2022.2068109
10.3390/cancers14163851
10.1158/0008-5472.CAN-21-3062
10.1128/JVI.03688-13
10.1038/s41571-022-00717-y
10.1016/j.oraloncology.2019.06.016
10.1038/nrm2199
10.1158/2643-3230.BCD-21-0047
10.1002/advs.202301759
10.1111/imr.12601
10.1038/sj.cdd.4402201
10.1038/s41572-020-0160-6
10.18632/oncotarget.4754
10.1038/s41419-020-2304-8
10.1080/15548627.2017.1386359
10.1007/s10495-020-01643-z
10.1038/nrcardio.2016.39
10.1038/nrd2682
10.1158/2159-8290.CD-22-0523
10.1016/j.omto.2019.05.002
10.1172/JCI35180
10.1038/nature00858
10.7164/antibiotics.25.271
10.7150/thno.62984
10.1038/s41388-021-01687-8
10.3390/cells11223672
10.1158/1078-0432.CCR-07-0517
10.1158/2159-8290.CD-20-0465
10.1126/scitranslmed.aae0105
10.4049/jimmunol.152.11.5398
10.1136/jitc-2020-001714
10.1007/s00262-012-1258-9
10.1155/2020/9053274
10.1016/j.bcp.2018.02.006
10.1186/s12967-023-04017-6
10.1038/cddis.2010.82
10.15698/cst2019.11.204
10.1038/s41569-020-0348-1
10.1080/2162402X.2022.2104551
10.1016/j.molcel.2017.12.015
10.1182/blood-2015-02-630335
10.1142/S0192415X20500962
10.1080/2162402X.2019.1710398
10.1002/ajh.26823
10.1016/bs.ircmb.2019.11.006
10.1038/s41420-020-00365-0
10.3389/fonc.2023.1167105
10.1021/acsabm.1c00861
10.15698/cst2019.11.202
10.1039/D3BM00700F
10.1016/j.immuni.2018.06.003
10.1016/j.biomaterials.2023.122278
10.1038/nm.3708
10.1073/pnas.012485299
10.1038/s41574-021-00484-3
10.1126/science.1224922
10.1016/j.jtho.2020.01.015
10.1007/s12192-013-0422-2
10.1126/scitranslmed.3003807
10.1038/nm1523
10.1038/32183
10.1038/s41598-021-86354-4
10.1016/j.it.2007.08.004
10.3390/cells9041033
10.1080/15548627.2020.1758417
10.4161/21624011.2014.955691
10.1038/s41419-020-2642-6
10.1158/1078-0432.CCR-09-2891
10.1016/j.cell.2011.02.013
10.1038/s41591-023-02336-1
10.1136/jitc-2019-000462
10.1039/D2TB01004F
10.1038/s41419-021-03997-x
10.1016/S1470-2045(19)30788-0
10.1038/s43018-020-00107-2
10.1038/s41572-019-0064-5
10.1080/10428194.2019.1599110
10.1038/s41467-019-09415-3
10.1038/emboj.2011.497
10.3390/ijms20040959
10.1016/j.immuni.2013.03.003
10.1039/d0mt00227e
10.1080/2162402X.2022.2093518
10.1074/jbc.273.50.33741
10.1016/j.canlet.2020.09.011
10.3389/fonc.2019.01196
10.1007/s12672-021-00439-0
10.1126/science.aad0779
10.1016/S1470-2045(19)30171-8
10.1038/s41423-022-00956-0
10.1038/sj.cdd.4402275
10.1158/0008-5472.CAN-20-1441
10.1136/jitc-2023-006785
10.1080/10799893.2019.1655050
10.1080/2162402X.2020.1721810
10.1126/sciadv.adf2746
10.1080/2162402X.2019.1656502
10.1038/cddis.2016.134
ContentType Journal Article
Copyright 2023 Elsevier Ltd
Copyright © 2023 Elsevier Ltd. All rights reserved.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2023 Elsevier Ltd
– notice: Copyright © 2023 Elsevier Ltd. All rights reserved.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
VOOES
DOI 10.1016/j.semcdb.2023.10.007
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1096-3634
EndPage 21
ExternalDocumentID oai:HAL:hal-04601413v1
37977108
10_1016_j_semcdb_2023_10_007
S1084952123002045
Genre Journal Article
Review
GroupedDBID ---
--K
--M
-DZ
.~1
0R~
123
1B1
1RT
1~.
4.4
457
4G.
5VS
71M
8P~
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABFRF
ABGSF
ABJNI
ABLJU
ABMAC
ABUDA
ABYKQ
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
DM4
DOVZS
DU5
EBS
EFBJH
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
IHE
J1W
KOM
LG5
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
~G-
1~5
53G
7-5
9DU
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ABXDB
ACLOT
ACRPL
ACVFH
ADCNI
ADFGL
ADMUD
ADNMO
ADVLN
AEIPS
AEUPX
AFFNX
AFJKZ
AFPUW
AGQPQ
AGRDE
AIGII
AIIUN
AKBMS
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
CAG
CITATION
COF
EFKBS
EFLBG
EJD
FGOYB
HX~
HZ~
R2-
UDS
XPP
ZMT
~HD
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
VOOES
ID FETCH-LOGICAL-c442t-78f15bfae2e781a3517626502414c5658b433b3c9c5f28efaa51962d4394a27a3
ISICitedReferencesCount 21
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001161963100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1084-9521
1096-3634
IngestDate Sat Nov 29 14:59:05 EST 2025
Wed Oct 01 09:18:43 EDT 2025
Wed Feb 19 02:04:16 EST 2025
Tue Nov 18 21:53:58 EST 2025
Sat Nov 29 07:06:41 EST 2025
Sat Apr 20 15:59:15 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords ICD
APC
ICI
DAMP
DC
dendritic cells ICD
immune checkpoint inhibitor
immunogenic cell death
antigen presenting cell DAMP
damage associated molecular pattern DC
dendritic cells
damage associated molecular pattern
antigen presenting cell
immunogenic cell death ICI
Language English
License Copyright © 2023 Elsevier Ltd. All rights reserved.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c442t-78f15bfae2e781a3517626502414c5658b433b3c9c5f28efaa51962d4394a27a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-6081-9558
0000-0002-9334-4405
OpenAccessLink https://hal.science/hal-04601413
PMID 37977108
PQID 2891759234
PQPubID 23479
PageCount 11
ParticipantIDs hal_primary_oai_HAL_hal_04601413v1
proquest_miscellaneous_2891759234
pubmed_primary_37977108
crossref_primary_10_1016_j_semcdb_2023_10_007
crossref_citationtrail_10_1016_j_semcdb_2023_10_007
elsevier_sciencedirect_doi_10_1016_j_semcdb_2023_10_007
PublicationCentury 2000
PublicationDate 2024-03-15
PublicationDateYYYYMMDD 2024-03-15
PublicationDate_xml – month: 03
  year: 2024
  text: 2024-03-15
  day: 15
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Seminars in cell & developmental biology
PublicationTitleAlternate Semin Cell Dev Biol
PublicationYear 2024
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Lee, Ha, Ahn, Jeong, Jeong, Park, Yun, Kim (bib98) 2021; 4
Kar, Jain, Kumar, Rajput, Pal, Rana, Kar, Jha, Medatwal, Yavvari (bib119) 2023; 9
Zhang, Kuo, Zhang, Huang, Lee (bib145) 2022; 111
Xu, Su, Mo, Zhao, Zhao, Li, Hu, Li (bib153) 2022; 23
Garbe, Dummer, Amaral, Amaria, Ascierto, Burton, Dreno, Eggermont, Hauschild, Hoeller (bib5) 2023; 29
Wang, Peng, Du, Chen (bib123) 2023; 13
Granato, Gilardini Montani, Filardi, Faggioni, Cirone (bib116) 2015; 6
Yamazaki, Kirchmair, Sato, Buque, Rybstein, Petroni, Bloy, Finotello, Stafford, Navarro Manzano (bib31) 2020; 21
Kepp, Kroemer (bib109) 2022; 11
Kostopoulos, Kakalis, Birmpilis, Angelis, Orologas-Stavrou, Rousakis, Panteli, Gavriatopoulou, Kastritis, Dimopoulos (bib132) 2023; 98
Fernandez-Ruiz (bib192) 2016; 13
Humeau, Sauvat, Cerrato, Xie, Loos (bib63) 2020; 12
Florencio, Edson, Fernandes, Luiz, Pinto, Pessoa, Cunha, Machado-Neto, Wilke (bib142) 2022; 13
Xie, Forveille, Iribarren, Sauvat, Senovilla, Wang, Humeau, Perez-Lanzon, Zhou, Martinez-Leal (bib149) 2019; 8
Fleten, Eksteen, Mauseth, Camilio, Vasskog, Sveinbjornsson, Rekdal, Maelandsmo, Flatmark (bib84) 2021; 11
Ren, Zhou, Liu, Jiao, Cao, Xu, Kang, Xue (bib81) 2021; 11
Ye, Jiang, Wei, Barr, Xu, Zhang, Ding, Meng, Piao (bib155) 2018; 8
Helmink, Gaudreau, Wargo (bib3) 2018; 48
Zitvogel, Apetoh, Ghiringhelli, Andre, Tesniere, Kroemer (bib4) 2008; 118
Forveille, Sauvat, Zhang, Zhao, Kroemer, Kepp (bib29) 2022; 172
Yamazaki, Buque, Ames, Galluzzi (bib70) 2020; 9
Zhou, Mondragon, Xie, Mauseth, Leduc, Sauvat, Gomes-da-Silva, Forveille, Iribarren, Souquere (bib89) 2018; 9
Xie, Mondragon, Mauseth, Wang, Pol, Levesque, Zhou, Yamazaki, Eksteen, Zitvogel (bib88) 2019; 8
Xu, Ge, An, Bai, Wang, Wu, Dai, Lu, Liu (bib106) 2023; 19
Pietrocola, Pol, Vacchelli, Baracco, Levesque, Castoldi, Maiuri, Madeo, Kroemer (bib179) 2016; 12
Pietrocola, Pol, Vacchelli, Rao, Enot, Baracco, Levesque, Castoldi, Jacquelot, Yamazaki (bib178) 2016; 30
Zhang, Gao, Yan, Wen, Lee, Liang, Liu (bib143) 2022; 17
Aaes, Kaczmarek, Delvaeye, De Craene, De Koker, Heyndrickx, Delrue, Taminau, Wiernicki, De Groote (bib51) 2016; 15
Ya, Guo, Li, Zhu, Zhang, Zong, Wan (bib120) 2023; 301
Huang, Wang, Chang, Chuang, Wang, Kao, Liang, Wu, Kao, Chen (bib97) 2020; 140
Le Naour, Liu, Zhao, Adjemian, Sztupinszki, Taieb, Mulot, Silvin, Dutertre, Ginhoux (bib18) 2021; 11
Rodrigues, de Sousa Junior, Mundim, Vale, de Oliveira, Ganassin, Pacheco, Vasconcelos Morais, Longo, Azevedo (bib103) 2022; 14
Zhao, Liu, Mao, Zhang, Bigenwald, Dutertre, Lehmann, Pan, Paulhan, Amon (bib189) 2023
Zhang, Neighbors, Schell, Hohl (bib65) 2022; 11
Ye, Gunti, Allen, Hong, Clavijo, Van Waes, Schmitt (bib128) 2020; 9
Uscanga-Palomeque, Calvillo-Rodriguez, Gomez-Morales, Larde, Denefle, Caballero-Hernandez, Merle-Beral, Susin, Karoyan, Martinez-Torres (bib165) 2019; 110
Wen, Zhong, Yin, Qin, Yang, Li, Yu, Yang, Deng, Hong (bib152) 2022; 18
Liu, Chen, Zhao, Hollebecque, Kepp, Zitvogel, Kroemer (bib196) 2022; 11
Zitvogel, Kroemer (bib72) 2021; 2
Ma, Adjemian, Mattarollo, Yamazaki, Aymeric, Yang, Portela Catani, Hannani, Duret, Steegh (bib28) 2013; 38
Shan, Du, Zhai, Wang, Li, Gong, Ge, Liu, Zhen (bib164) 2021; 87
Wernitznig, Meier-Menches, Cseh, Theiner, Wenisch, Schweikert, Jakupec, Koellensperger, Wernitznig, Sommergruber (bib169) 2020; 12
Wu, Tian, Durand, Aprahamian, Nirmalathasan, Xie, Liu, Zhao, Zhang, Pan (bib136) 2020; 11
Li, Zhang, Li, Zou, Huang, Wu, Tan (bib173) 2020; 495
Egelston, Guo, Yost, Ge, Lee, Frankel, Cui, Ruel, Schmolze, Murga (bib197) 2023; 72
Jiang, Zhang, Wang, Peng, Zhang, Wang, Han, Shi (bib144) 2019; 9
Abdalbari, Telleria (bib130) 2021; 12
Sistigu, Yamazaki, Vacchelli, Chaba, Enot, Adam, Vitale, Goubar, Baracco, Remedios (bib27) 2014; 20
Kepp, Sauvat, Leduc, Forveille, Liu, Zhao, Bezu, Xie, Zitvogel, Kroemer (bib74) 2019; 8
Arai, Xiao, Loupakis, Kawanishi, Wang, Battaglin, Soni, Zhang, Mancao, Salhia (bib160) 2020; 8
Lu, Xu, Wang, Shi, Sha, He, Yao, Shao, Sun, Du (bib44) 2021; 278
Menger, Vacchelli, Adjemian, Martins, Ma, Shen, Yamazaki, Sukkurwala, Michaud, Mignot (bib73) 2012; 4
Galluzzi, Kepp, Hett, Kroemer, Marincola (bib40) 2023; 21
Zhou, Forveille, Sauvat, Yamazaki, Senovilla, Ma, Liu, Yang, Bezu, Muller (bib91) 2016; 7
Zhong, Han, Tourkova, Lokshin, Rosenbloom, Shurin, Shurin (bib163) 2007; 13
Angelova, Grekova, Heller, Kuhlmann, Soyka, Giese, Aprahamian, Bour, Ruffer, Cziepluch (bib93) 2014; 88
Panaretakis, Joza, Modjtahedi, Tesniere, Vitale, Durchschlag, Fimia, Kepp, Piacentini, Froehlich (bib38) 2008; 15
Hanahan, Weinberg (bib1) 2011; 144
Park, Ye, Xiao, Silvin, Padget, Hodge, Van Waes, Schmitt (bib159) 2019; 95
Polajzer, Miklavcic (bib111) 2023
Sequeira, Sahores, Dalotto-Moreno, Perrotta, Pataccini, Vanzulli, Polo, Radisky, Sartorius, Novaro (bib150) 2021; 81
Song, Lee, Ermolenko, Mazumder, Ji, Ryu, Kim, Kim, Lee, Dicato (bib177) 2020; 11
Marin, Boix, Garcia-Garijo, Sirois, Caballe, Zarzuela, Ruano, Attolini, Prats, Lopez-Dominguez (bib47) 2023; 13
van Vloten, Workenhe, Wootton, Mossman, Bridle (bib14) 2018; 200
Petrazzuolo, Perez-Lanzon, Martins, Liu, Kepp, Minard-Colin, Maiuri, Kroemer (bib183) 2021; 12
Petrazzuolo, Perez-Lanzon, Liu, Maiuri, Kroemer (bib12) 2021; 10
Obeid, Panaretakis, Joza, Tufi, Tesniere, van Endert, Zitvogel, Kroemer (bib99) 2007; 14
Prieto, Lozano, Uruena, Almeciga-Diaz, Fiorentino, Barreto (bib161) 2020; 25
De Ruysscher, Niedermann, Burnet, Siva, Lee, Hegi-Johnson (bib190) 2019; 5
Clucas, Meier (bib46) 2023
Li, Chu, Yang, Qian, Xu, Chen, Tian, Chen, Xu, Wang (bib184) 2022; 16
Chen, Wang, Chen, Wen, Chen, Yang, Yang (bib171) 2012; 61
Trigo, Subbiah, Besse, Moreno, Lopez, Sala, Peters, Ponce, Fernandez, Alfaro (bib198) 2020; 21
Bezu, Wu Chuang, Sauvat, Humeau, Xie, Cerrato, Liu, Zhao, Zhang, Le Naour (bib114) 2022; 10
Wemeau, Kepp, Tesniere, Panaretakis, Flament, De Botton, Zitvogel, Kroemer, Chaput (bib64) 2010; 1
Tong, Tan, Song, Gao, Risnik, Hao, Ermine, Wang, Li, Huang (bib141) 2022; 82
Kepp, Kroemer (bib181) 2020; 16
Apetoh, Ghiringhelli, Tesniere, Obeid, Ortiz, Criollo, Mignot, Maiuri, Ullrich, Saulnier (bib26) 2007; 13
Aurelius, Mollgard, Kiffin, Ewald Sander, Nilsson, Thoren, Hellstrand, Martner (bib59) 2019; 60
Kepp, Liu, Kroemer, Galluzzi (bib188) 2023; 12
Ren, Wang, Liang, Zheng, Shi, Cheng, Li, Gu (bib78) 2023
Jiang (bib113) 2022; 16
Sharma, Goswami, Raychaudhuri, Siddiqui, Singh, Nagarajan, Liu, Subudhi, Poon, Gant (bib2) 2023; 186
Zweytick (bib85) 2019; 3
Ishimwe, Wei, Wang, Zhang, Wang, Jing, Wen, Zhang (bib133) 2020; 48
Kepp, Pan, Liu, Kroemer (bib42) 2023; 12
Jomon, Kuroda, Ajisaka, Sakai (bib186) 1972; 25
Chen, Jin, Zhang, Zhang, Li, Yang, Ma (bib126) 2023; 20
Sun, Cui, Li, Chen, Song, Li (bib157) 2019; 39
Liu, Kroemer, Kepp (bib187) 2023; 12
Kroemer, Kepp (bib6) 2021; 10
Shao, Wang, Guo, Jiang, Ye, Chen, Fang, Gu, Wang, Zhang (bib156) 2019; 9
Ramos-Casals, Brahmer, Callahan, Flores-Chavez, Keegan, Khamashta, Lambotte, Mariette, Prat, Suarez-Almazor (bib194) 2020; 6
Gomes-da-Silva, Zhao, Bezu, Zhou, Sauvat, Liu, Durand, Leduc, Souquere, Loos (bib102) 2018; 37
Fucikova, Truxova, Hensler, Becht, Kasikova, Moserova, Vosahlikova, Klouckova, Church, Cremer (bib199) 2016; 128
Tesniere, Panaretakis, Kepp, Apetoh, Ghiringhelli, Zitvogel, Kroemer (bib36) 2008; 15
Lau, Chan, Man, Wong, Lee, Yim, Cheung, McNeish, Kwong (bib68) 2020; 8
Liu P., Zhao L., Pol J., Levesque S., Petrazzuolo A., Pfirschke C., Engblom C., Rickelt S. Crizotinib-induced immunogenic cell death in non-small cell lung cancer. 2019;10(1):1486.
Tang, Kepp, Kroemer (bib48) 2020; 10
Leshem, King, Mazor, Reiter, Pastan (bib174) 2018; 10
Gulla, Morelli, Samur, Botta, Hideshima, Bianchi, Fulciniti, Malvestiti, Prabhala, Talluri (bib71) 2021; 2
Panaretakis, Kepp, Brockmeier, Tesniere, Bjorklund, Chapman, Durchschlag, Joza, Pierron, van Endert (bib39) 2009; 28
Spisek, Charalambous, Mazumder, Vesole, Jagannath, Dhodapkar (bib24) 2007; 109
Lotsberg, Wnuk-Lipinska, Terry, Tan, Lu, Trachsel-Moncho, Rosland, Siraji, Hellesoy, Rayford (bib131) 2020; 15
Kepp, Kroemer (bib110) 2020; 1
Prassas, Diamandis (bib139) 2008; 7
Talloczy, Jiang (bib60) 2002; 99
Rapoport, Anderson (bib7) 2019; 20
Montes de Oca, Alavi, Vitali, Bhattacharya, Blackwell, Patel, Seestaller-Wehr, Kaczynski, Shi, Dobrzynski (bib95) 2021; 20
Kofla, Radecke, Frentsch, Walther, Stintzing, Riess, Bullinger, Na (bib124) 2022; 11
Li, Zheng, Chen, Meng, Ning, Sun (bib75) 2021; 12
Kopecka, Godel, Dei, Giampietro, Belisario, Akman, Contino, Teodori, Riganti (bib166) 2020; 9
Sprooten, Laureano, Vanmeerbeek, Govaerts, Naulaerts, Borras, Kinget, Fucikova, Spisek, Jelinkova (bib9) 2023; 12
Turubanova, Mishchenko (bib104) 2021; 11
Nestvold, Wang, Camilio, Zinocker, Tjelle, Lindberg, Haug, Kvalheim, Sveinbjornsson, Rekdal (bib90) 2017; 6
Wang, Ren, Feng, Chen, Ju (bib148) 2018; 57
Yan, Liu, Wang, Li, Jiao, Lee, Zhang, Hou, Hou, Ma (bib112) 2022; 10
Humeau, Leduc, Cerrato, Loos, Kepp, Kroemer (bib61) 2020; 11
Hernandez, Huebener, Schwabe (bib17) 2016; 35
Kepp, Marabelle, Zitvogel, Kroemer (bib92) 2020; 17
D'Eliseo, Manzi, Velotti (bib137) 2013; 18
Coloff (bib54) 2018; 69
Ecker, Stumpf, Brandmeier, Neumayer, Pfeuffer, Engleitner, Ringshausen, Nelson, Jucker, Wanninger (bib172) 2021; 12
Hayashi, Nikolos, Lee, Jain, Tsouko, Gao, Kasabyan, Leung, Osipov, Jung (bib33) 2020; 11
Ron, Walter (bib52) 2007; 8
Roemhild, Besse, Wang, Pena, Sun, Omata, Ozbakir, Bos, Scheeren, Storm (bib80) 2022; 12
Tukaramrao, Malla, Saraiya, Hanely, Ray, Kumari, Raman, Tiwari (bib176) 2021; 13
Freire Boullosa, Van Loenhout, Flieswasser, De Waele, Hermans, Lambrechts, Cuypers, Laukens, Bartholomeus, Siozopoulou (bib129) 2021; 42
Bianchi, Crippa, Manfredi, Mezzapelle, Rovere Querini, Venereau (bib34) 2017; 280
Liao, Garris, Pfirschke, Rickelt, Arlauckas, Siwicki, Kohler, Weissleder, Sundvold-Gjerstad, Sveinbjornsson (bib86) 2019; 3
Zhou, Lyu, Liu, Su, Feng, Zhang (bib121) 2023
Slingerland, Cerella, Guchelaar, Diederich, Gelderblom (bib140) 2013; 31
Chen, Xie, Nah, Sauvat, Liu (bib134) . 2019
Michaud, Martins, Sukkurwala, Adjemian, Ma, Pellegatti, Shen, Kepp, Scoazec, Mignot (bib20) 2
Kroemer (10.1016/j.semcdb.2023.10.007_bib6) 2021; 10
Rapoport (10.1016/j.semcdb.2023.10.007_bib7) 2019; 20
Castoldi (10.1016/j.semcdb.2023.10.007_bib135) 2020; 6
Kepp (10.1016/j.semcdb.2023.10.007_bib188) 2023; 12
Xu (10.1016/j.semcdb.2023.10.007_bib106) 2023; 19
Jiang (10.1016/j.semcdb.2023.10.007_bib144) 2019; 9
Fleten (10.1016/j.semcdb.2023.10.007_bib84) 2021; 11
Pol (10.1016/j.semcdb.2023.10.007_bib125) 2015; 4
Chen (10.1016/j.semcdb.2023.10.007_bib171) 2012; 61
Chen (10.1016/j.semcdb.2023.10.007_bib134) 2019
Efimova (10.1016/j.semcdb.2023.10.007_bib49) 2020; 8
Udono (10.1016/j.semcdb.2023.10.007_bib23) 1994; 152
Marin (10.1016/j.semcdb.2023.10.007_bib47) 2023; 13
Bianchi (10.1016/j.semcdb.2023.10.007_bib34) 2017; 280
Gomes-da-Silva (10.1016/j.semcdb.2023.10.007_bib102) 2018; 37
Nestvold (10.1016/j.semcdb.2023.10.007_bib90) 2017; 6
Spisek (10.1016/j.semcdb.2023.10.007_bib24) 2007; 109
Huang (10.1016/j.semcdb.2023.10.007_bib97) 2020; 140
Kostopoulos (10.1016/j.semcdb.2023.10.007_bib132) 2023; 98
Ren (10.1016/j.semcdb.2023.10.007_bib78) 2023
Zhang (10.1016/j.semcdb.2023.10.007_bib145) 2022; 111
Aurelius (10.1016/j.semcdb.2023.10.007_bib59) 2019; 60
Deutsch (10.1016/j.semcdb.2023.10.007_bib100) 2019; 20
Pietrocola (10.1016/j.semcdb.2023.10.007_bib179) 2016; 12
Gulla (10.1016/j.semcdb.2023.10.007_bib71) 2021; 2
Wang (10.1016/j.semcdb.2023.10.007_bib147) 2022; 74
von Hofsten (10.1016/j.semcdb.2023.10.007_bib77) 2022; 12
Kepp (10.1016/j.semcdb.2023.10.007_bib57) 2015; 33
Shao (10.1016/j.semcdb.2023.10.007_bib156) 2019; 9
Humeau (10.1016/j.semcdb.2023.10.007_bib61) 2020; 11
Gomez-Cadena (10.1016/j.semcdb.2023.10.007_bib162) 2016; 7
Zhou (10.1016/j.semcdb.2023.10.007_bib91) 2016; 7
Herrmann (10.1016/j.semcdb.2023.10.007_bib191) 2020; 17
Ye (10.1016/j.semcdb.2023.10.007_bib155) 2018; 8
Freire Boullosa (10.1016/j.semcdb.2023.10.007_bib129) 2021; 42
Rodrigues (10.1016/j.semcdb.2023.10.007_bib103) 2022; 14
Green (10.1016/j.semcdb.2023.10.007_bib8) 2009; 9
Uscanga-Palomeque (10.1016/j.semcdb.2023.10.007_bib165) 2019; 110
Radogna (10.1016/j.semcdb.2023.10.007_bib16) 2018; 153
Abdalbari (10.1016/j.semcdb.2023.10.007_bib130) 2021; 12
Ya (10.1016/j.semcdb.2023.10.007_bib120) 2023; 301
Roemhild (10.1016/j.semcdb.2023.10.007_bib80) 2022; 12
Guilbaud (10.1016/j.semcdb.2023.10.007_bib21) 2023; 41
Yang (10.1016/j.semcdb.2023.10.007_bib32) 2018; 7
Ye (10.1016/j.semcdb.2023.10.007_bib128) 2020; 9
Petrazzuolo (10.1016/j.semcdb.2023.10.007_bib183) 2021; 12
Tong (10.1016/j.semcdb.2023.10.007_bib141) 2022; 82
Kepp (10.1016/j.semcdb.2023.10.007_bib42) 2023; 12
Jin (10.1016/j.semcdb.2023.10.007_bib138) 2016; 12
Slingerland (10.1016/j.semcdb.2023.10.007_bib140) 2013; 31
Zhu (10.1016/j.semcdb.2023.10.007_bib108) 2023; 18
Tukaramrao (10.1016/j.semcdb.2023.10.007_bib176) 2021; 13
Le Naour (10.1016/j.semcdb.2023.10.007_bib18) 2021; 11
Liu (10.1016/j.semcdb.2023.10.007_bib105) 2022; 16
Kofla (10.1016/j.semcdb.2023.10.007_bib124) 2022; 11
Lu (10.1016/j.semcdb.2023.10.007_bib44) 2021; 278
Garg (10.1016/j.semcdb.2023.10.007_bib58) 2015; 6
Li (10.1016/j.semcdb.2023.10.007_bib75) 2021; 12
Galassi (10.1016/j.semcdb.2023.10.007_bib101) 2023
Kepp (10.1016/j.semcdb.2023.10.007_bib15) 2014; 3
Ramos-Casals (10.1016/j.semcdb.2023.10.007_bib194) 2020; 6
Zweytick (10.1016/j.semcdb.2023.10.007_bib85) 2019; 3
Li (10.1016/j.semcdb.2023.10.007_bib184) 2022; 16
Li (10.1016/j.semcdb.2023.10.007_bib173) 2020; 495
Egelston (10.1016/j.semcdb.2023.10.007_bib197) 2023; 72
Tang (10.1016/j.semcdb.2023.10.007_bib48) 2020; 10
Leshem (10.1016/j.semcdb.2023.10.007_bib174) 2018; 10
Hanurry (10.1016/j.semcdb.2023.10.007_bib79) 2022; 8
Vitale (10.1016/j.semcdb.2023.10.007_bib83) 2021; 7
Song (10.1016/j.semcdb.2023.10.007_bib177) 2020; 11
Fletcher (10.1016/j.semcdb.2023.10.007_bib154) 2021; 40
Ecker (10.1016/j.semcdb.2023.10.007_bib172) 2021; 12
Scaffidi (10.1016/j.semcdb.2023.10.007_bib25) 2002; 418
Yoshida (10.1016/j.semcdb.2023.10.007_bib55) 1998; 273
Ma (10.1016/j.semcdb.2023.10.007_bib28) 2013; 38
Lee (10.1016/j.semcdb.2023.10.007_bib98) 2021; 4
Stoll (10.1016/j.semcdb.2023.10.007_bib195) 2016; 5
Chen (10.1016/j.semcdb.2023.10.007_bib126) 2023; 20
Yamazaki (10.1016/j.semcdb.2023.10.007_bib82) 2021; 10
Sukkurwala (10.1016/j.semcdb.2023.10.007_bib76) 2014; 3
Lin (10.1016/j.semcdb.2023.10.007_bib50) 2018; 14
Florencio (10.1016/j.semcdb.2023.10.007_bib142) 2022; 13
Lin (10.1016/j.semcdb.2023.10.007_bib182) 2015; 14
Trigo (10.1016/j.semcdb.2023.10.007_bib198) 2020; 21
Wu (10.1016/j.semcdb.2023.10.007_bib136) 2020; 11
Karp (10.1016/j.semcdb.2023.10.007_bib167) 2022; 49
Xu (10.1016/j.semcdb.2023.10.007_bib153) 2022; 23
Liao (10.1016/j.semcdb.2023.10.007_bib86) 2019; 3
Soler-Agesta (10.1016/j.semcdb.2023.10.007_bib168) 2022; 14
Hayashi (10.1016/j.semcdb.2023.10.007_bib33) 2020; 11
Zitvogel (10.1016/j.semcdb.2023.10.007_bib53) 2010; 16
Clucas (10.1016/j.semcdb.2023.10.007_bib46) 2023
Kepp (10.1016/j.semcdb.2023.10.007_bib109) 2022; 11
10.1016/j.semcdb.2023.10.007_bib11
Roussot (10.1016/j.semcdb.2023.10.007_bib30) 2022; 11
Wright (10.1016/j.semcdb.2023.10.007_bib193) 2021; 17
Turubanova (10.1016/j.semcdb.2023.10.007_bib104) 2021; 11
Michaud (10.1016/j.semcdb.2023.10.007_bib20) 2011; 334
Wu Chuang (10.1016/j.semcdb.2023.10.007_bib66) 2020; 350
Forveille (10.1016/j.semcdb.2023.10.007_bib29) 2022; 172
D'Eliseo (10.1016/j.semcdb.2023.10.007_bib137) 2013; 18
Sistigu (10.1016/j.semcdb.2023.10.007_bib27) 2014; 20
Tufi (10.1016/j.semcdb.2023.10.007_bib37) 2008; 15
Petrazzuolo (10.1016/j.semcdb.2023.10.007_bib12) 2021; 10
Wen (10.1016/j.semcdb.2023.10.007_bib152) 2022; 18
Shan (10.1016/j.semcdb.2023.10.007_bib164) 2021; 87
Humeau (10.1016/j.semcdb.2023.10.007_bib62) 2020; 7
Kepp (10.1016/j.semcdb.2023.10.007_bib110) 2020; 1
Arai (10.1016/j.semcdb.2023.10.007_bib160) 2020; 8
Jomon (10.1016/j.semcdb.2023.10.007_bib186) 1972; 25
Fernandez-Ruiz (10.1016/j.semcdb.2023.10.007_bib192) 2016; 13
Ren (10.1016/j.semcdb.2023.10.007_bib81) 2021; 11
Montes de Oca (10.1016/j.semcdb.2023.10.007_bib95) 2021; 20
De Ruysscher (10.1016/j.semcdb.2023.10.007_bib190) 2019; 5
Panaretakis (10.1016/j.semcdb.2023.10.007_bib38) 2008; 15
Yamazaki (10.1016/j.semcdb.2023.10.007_bib70) 2020; 9
Sun (10.1016/j.semcdb.2023.10.007_bib157) 2019; 39
Cheadle (10.1016/j.semcdb.2023.10.007_bib96) 2013; 162
Sprooten (10.1016/j.semcdb.2023.10.007_bib9) 2023; 12
Jiang (10.1016/j.semcdb.2023.10.007_bib113) 2022; 16
Lotsberg (10.1016/j.semcdb.2023.10.007_bib131) 2020; 15
van Vloten (10.1016/j.semcdb.2023.10.007_bib14) 2018; 200
Wang (10.1016/j.semcdb.2023.10.007_bib175) 2020; 8
Wang (10.1016/j.semcdb.2023.10.007_bib180) 2022; 13
Obeid (10.1016/j.semcdb.2023.10.007_bib99) 2007; 14
Rook (10.1016/j.semcdb.2023.10.007_bib146) 2015; 126
Lonial (10.1016/j.semcdb.2023.10.007_bib94) 2020; 21
Prieto (10.1016/j.semcdb.2023.10.007_bib161) 2020; 25
Sequeira (10.1016/j.semcdb.2023.10.007_bib150) 2021; 81
Kepp (10.1016/j.semcdb.2023.10.007_bib45) 2022; 11
Wemeau (10.1016/j.semcdb.2023.10.007_bib64) 2010; 1
Apetoh (10.1016/j.semcdb.2023.10.007_bib26) 2007; 13
Park (10.1016/j.semcdb.2023.10.007_bib159) 2019; 95
Tesniere (10.1016/j.semcdb.2023.10.007_bib158) 2010; 29
Coloff (10.1016/j.semcdb.2023.10.007_bib54) 2018; 69
Kopecka (10.1016/j.semcdb.2023.10.007_bib166) 2020; 9
Yamazaki (10.1016/j.semcdb.2023.10.007_bib31) 2020; 21
Zitvogel (10.1016/j.semcdb.2023.10.007_bib72) 2021; 2
Tesniere (10.1016/j.semcdb.2023.10.007_bib36) 2008; 15
Casares (10.1016/j.semcdb.2023.10.007_bib67) 2005; 202
Hernandez (10.1016/j.semcdb.2023.10.007_bib17) 2016; 35
Garg (10.1016/j.semcdb.2023.10.007_bib56) 2012; 31
Huang (10.1016/j.semcdb.2023.10.007_bib118) 2021; 26
Kepp (10.1016/j.semcdb.2023.10.007_bib74) 2019; 8
Bezu (10.1016/j.semcdb.2023.10.007_bib114) 2022; 10
Albert (10.1016/j.semcdb.2023.10.007_bib41) 1998; 392
Senovilla (10.1016/j.semcdb.2023.10.007_bib69) 2012; 337
Xie (10.1016/j.semcdb.2023.10.007_bib88) 2019; 8
Di Grazia (10.1016/j.semcdb.2023.10.007_bib170) 2020; 12
Prassas (10.1016/j.semcdb.2023.10.007_bib139) 2008; 7
Zhao (10.1016/j.semcdb.2023.10.007_bib189) 2023
Liu (10.1016/j.semcdb.2023.10.007_bib10) 2019; 8
Kar (10.1016/j.semcdb.2023.10.007_bib119) 2023; 9
Obeid (10.1016/j.semcdb.2023.10.007_bib22) 2007; 13
Liu (10.1016/j.semcdb.2023.10.007_bib196) 2022; 11
Zhang (10.1016/j.semcdb.2023.10.007_bib122) 2023; 10
Pietrocola (10.1016/j.semcdb.2023.10.007_bib178) 2016; 30
Zhong (10.1016/j.semcdb.2023.10.007_bib163) 2007; 13
Kepp (10.1016/j.semcdb.2023.10.007_bib181) 2020; 16
Xie (10.1016/j.semcdb.2023.10.007_bib149) 2019; 8
Helmink (10.1016/j.semcdb.2023.10.007_bib3) 2018; 48
Wang (10.1016/j.semcdb.2023.10.007_bib123) 2023; 13
Hanahan (10.1016/j.semcdb.2023.10.007_bib1) 2011; 144
Zhou (10.1016/j.semcdb.2023.10.007_bib89) 2018; 9
Quan (10.1016/j.semcdb.2023.10.007_bib115) 2020; 2020
Kepp (10.1016/j.semcdb.2023.10.007_bib92) 2020; 17
Aaes (10.1016/j.semcdb.2023.10.007_bib51) 2016; 15
Lau (10.1016/j.semcdb.2023.10.007_bib68) 2020; 8
Yang (10.1016/j.semcdb.2023.10.007_bib43) 2016; 5
Wang (10.1016/j.semcdb.2023.10.007_bib107) 2023; 11
Panaretakis (10.1016/j.semcdb.2023.10.007_bib39) 2009; 28
Sharma (10.1016/j.semcdb.2023.10.007_bib2) 2023; 186
Granato (10.1016/j.semcdb.2023.10.007_bib116) 2015; 6
Yan (10.1016/j.semcdb.2023.10.007_bib112) 2022; 10
Garbe (10.1016/j.semcdb.2023.10.007_bib5) 2023; 29
Galluzzi (10.1016/j.semcdb.2023.10.007_bib40) 2023; 21
Zitvogel (10.1016/j.semcdb.2023.10.007_bib4) 2008; 118
Wang (10.1016/j.semcdb.2023.10.007_bib148) 2018; 57
Angelova (10.1016/j.semcdb.2023.10.007_bib93) 2014; 88
Fucikova (10.1016/j.semcdb.2023.10.007_bib199) 2016; 128
Polajzer (10.1016/j.semcdb.2023.10.007_bib111) 2023
Vacchelli (10.1016/j.semcdb.2023.10.007_bib19) 2015; 350
Garg (10.1016/j.semcdb.2023.10.007_bib13) 2016; 8
Talloczy (10.1016/j.semcdb.2023.10.007_bib60) 2002; 99
Ishimwe (10.1016/j.semcdb.2023.10.007_bib133) 2020; 48
Ron (10.1016/j.semcdb.2023.10.007_bib52) 2007; 8
Mauseth (10.1016/j.semcdb.2023.10.007_bib87) 2019; 14
Rubartelli (10.1016/j.semcdb.2023.10.007_bib35) 2007; 28
Xu (10.1016/j.semcdb.2023.10.007_bib151) 2022; 54
Liu (10.1016/j.semcdb.2023.10.007_bib185) 2023
Zhang (10.1016/j.semcdb.2023.10.007_bib65) 2022; 11
Zhang (10.1016/j.se
References_xml – volume: 202
  start-page: 1691
  year: 2005
  end-page: 1701
  ident: bib67
  article-title: Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
  publication-title: J. Exp. Med
– volume: 9
  start-page: 1721810
  year: 2020
  ident: bib70
  article-title: PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models
  publication-title: Oncoimmunology
– volume: 162
  start-page: 842
  year: 2013
  end-page: 845
  ident: bib96
  article-title: The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab
  publication-title: Br. J. Haematol.
– volume: 8
  start-page: 1099
  year: 2020
  end-page: 1111
  ident: bib68
  article-title: Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4/IKK2/SNARE-dependent exocytosis
  publication-title: Cancer Immunol. Res
– volume: 29
  start-page: 1310
  year: 2023
  end-page: 1312
  ident: bib5
  article-title: Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
  publication-title: Nat. Med
– volume: 17
  start-page: 49
  year: 2020
  end-page: 64
  ident: bib92
  article-title: Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies
  publication-title: Nat. Rev. Clin. Oncol.
– volume: 31
  start-page: 1087
  year: 2013
  end-page: 1094
  ident: bib140
  article-title: Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials
  publication-title: Investig. N. Drugs
– volume: 6
  start-page: 38
  year: 2020
  ident: bib194
  article-title: Immune-related adverse events of checkpoint inhibitors
  publication-title: Nat. Rev. Dis. Prim.
– volume: 9
  start-page: 353
  year: 2009
  end-page: 363
  ident: bib8
  article-title: Immunogenic and tolerogenic cell death
  publication-title: Nat. Rev. Immunol.
– volume: 41
  start-page: 1014
  year: 2023
  end-page: 1016
  ident: bib21
  article-title: Calreticulin exposure orchestrates innate immunosurveillance
  publication-title: Cancer Cell
– volume: 15
  start-page: 1499
  year: 2008
  end-page: 1509
  ident: bib38
  article-title: The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
  publication-title: Cell Death Differ.
– volume: 11
  start-page: 109
  year: 2020
  ident: bib177
  article-title: Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia
  publication-title: Cell Death Dis.
– volume: 88
  start-page: 5263
  year: 2014
  end-page: 5276
  ident: bib93
  article-title: Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer
  publication-title: J. Virol.
– volume: 12
  start-page: 713
  year: 2021
  ident: bib183
  article-title: Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
  publication-title: Cell Death Dis.
– volume: 13
  start-page: 410
  year: 2023
  end-page: 431
  ident: bib47
  article-title: Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
  publication-title: Cancer Discov.
– volume: 3
  year: 2014
  ident: bib15
  article-title: Consensus guidelines for the detection of immunogenic cell death
  publication-title: Oncoimmunology
– volume: 8
  start-page: 1594555
  year: 2019
  ident: bib88
  article-title: Tumor lysis with LTX-401 creates anticancer immunity
  publication-title: Oncoimmunology
– volume: 11
  start-page: 2093518
  year: 2022
  ident: bib196
  article-title: PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
  publication-title: Oncoimmunology
– volume: 87
  start-page: 425
  year: 2021
  end-page: 436
  ident: bib164
  article-title: Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8(+) T cell augmentation
  publication-title: Cancer Chemother. Pharm.
– volume: 17
  start-page: 474
  year: 2020
  end-page: 502
  ident: bib191
  article-title: Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
  publication-title: Nat. Rev. Cardiol.
– volume: 69
  start-page: 1
  year: 2018
  end-page: 2
  ident: bib54
  article-title: Glutamate Dehydrogenase to the Rescue
  publication-title: Mol. Cell
– volume: 8
  start-page: 1606665
  year: 2019
  ident: bib74
  article-title: A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers
  publication-title: Oncoimmunology
– volume: 16
  start-page: 15471
  year: 2022
  end-page: 15483
  ident: bib184
  article-title: Immunogenic cell death augmented by manganese zinc sulfide nanoparticles for metastatic melanoma immunotherapy
  publication-title: ACS Nano
– volume: 337
  start-page: 1678
  year: 2012
  end-page: 1684
  ident: bib69
  article-title: An immunosurveillance mechanism controls cancer cell ploidy
  publication-title: Science
– volume: 8
  start-page: 328ra27
  year: 2016
  ident: bib13
  article-title: Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
  publication-title: Sci. Transl. Med
– volume: 13
  start-page: 1050
  year: 2007
  end-page: 1059
  ident: bib26
  article-title: Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
  publication-title: Nat. Med
– volume: 12
  start-page: 2271693
  year: 2023
  ident: bib188
  article-title: A mitochondrial checkpoint to adaptive anticancer immunity
  publication-title: Oncoimmunology
– volume: 16
  start-page: 1166
  year: 2020
  end-page: 1167
  ident: bib181
  article-title: Autophagy induction by thiostrepton for the improvement of anticancer therapy
  publication-title: Autophagy
– volume: 140
  start-page: 1771
  year: 2020
  end-page: 1783
  ident: bib97
  article-title: Imiquimod exerts antitumor effects by inducing immunogenic cell death and is enhanced by the glycolytic inhibitor 2-deoxyglucose
  publication-title: J. Invest Dermatol.
– volume: 13
  year: 2021
  ident: bib176
  article-title: A novel thienopyrimidine analog, TPH104, mediates immunogenic cell death in triple-negative breast cancer cells
  publication-title: Cancers
– volume: 418
  start-page: 191
  year: 2002
  end-page: 195
  ident: bib25
  article-title: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
  publication-title: Nature
– volume: 11
  start-page: 2127273
  year: 2022
  ident: bib45
  article-title: Is ferroptosis immunogenic? The devil is in the details!
  publication-title: Oncoimmunology
– volume: 12
  start-page: 42
  year: 2021
  ident: bib130
  article-title: The gold complex auranofin: new perspectives for cancer therapy
  publication-title: Discov. Oncol.
– volume: 15
  start-page: 3
  year: 2008
  end-page: 12
  ident: bib36
  article-title: Molecular characteristics of immunogenic cancer cell death
  publication-title: Cell Death Differ.
– volume: 21
  start-page: 207
  year: 2020
  end-page: 221
  ident: bib94
  article-title: Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
  publication-title: Lancet Oncol.
– year: 2023
  ident: bib78
  article-title: Local drug delivery techniques for triggering immunogenic cell death
  publication-title: Small Methods
– volume: 14
  start-page: 1848
  year: 2007
  end-page: 1850
  ident: bib99
  article-title: Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis
  publication-title: Cell Death Differ.
– volume: 12
  start-page: 1962
  year: 2016
  end-page: 1964
  ident: bib179
  article-title: Autophagy induction for the treatment of cancer
  publication-title: Autophagy
– volume: 350
  start-page: 972
  year: 2015
  end-page: 978
  ident: bib19
  article-title: Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
  publication-title: Science
– year: 2023
  ident: bib101
  article-title: Molecular determinants of immunogenic cell death elicited by radiation therapy
  publication-title: Immunol. Rev.
– volume: 10
  start-page: 1862949
  year: 2020
  ident: bib48
  article-title: Ferroptosis becomes immunogenic: implications for anticancer treatments
  publication-title: Oncoimmunology
– volume: 12
  start-page: 2121
  year: 2020
  end-page: 2133
  ident: bib169
  article-title: Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids
  publication-title: Metallomics
– volume: 10
  start-page: 1962592
  year: 2021
  ident: bib82
  article-title: LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
  publication-title: Oncoimmunology
– volume: 15
  start-page: 973
  year: 2020
  end-page: 999
  ident: bib131
  article-title: AXL targeting abrogates autophagic flux and induces immunogenic cell death in drug-resistant cancer cells
  publication-title: J. Thorac. Oncol.
– volume: 25
  start-page: 875
  year: 2020
  end-page: 888
  ident: bib161
  article-title: The delay in cell death caused by the induction of autophagy by P2Et extract is essential for the generation of immunogenic signals in melanoma cells
  publication-title: Apoptosis
– volume: 10
  year: 2018
  ident: bib174
  article-title: SS1P immunotoxin induces markers of immunogenic cell death and enhances the effect of the CTLA-4 BLOCKADe in AE17M mouse mesothelioma tumors
  publication-title: Toxins
– volume: 1
  year: 2010
  ident: bib64
  article-title: Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
  publication-title: Cell Death Dis.
– volume: 495
  start-page: 12
  year: 2020
  end-page: 21
  ident: bib173
  article-title: CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer
  publication-title: Cancer Lett.
– volume: 19
  year: 2023
  ident: bib106
  article-title: Molecular engineering of NIR-II/IIb emitting AIEgen for multimodal imaging-guided photo-immunotherapy
  publication-title: Small
– volume: 30
  start-page: 147
  year: 2016
  end-page: 160
  ident: bib178
  article-title: Caloric restriction mimetics enhance anticancer immunosurveillance
  publication-title: Cancer Cell
– volume: 392
  start-page: 86
  year: 1998
  end-page: 89
  ident: bib41
  article-title: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
  publication-title: Nature
– volume: 10
  start-page: 1996686
  year: 2021
  ident: bib6
  article-title: Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
  publication-title: Oncoimmunology
– volume: 74
  start-page: 640
  year: 2022
  end-page: 649
  ident: bib147
  article-title: Immunogenic Cell Death (ICD) of Murine H22 Cells Induced by Lentinan
  publication-title: Nutr. Cancer
– volume: 11
  start-page: 9470
  year: 2021
  end-page: 9491
  ident: bib81
  article-title: Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem
  publication-title: Theranostics
– volume: 278
  year: 2021
  ident: bib44
  article-title: Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate
  publication-title: Biomaterials
– volume: 7
  year: 2016
  ident: bib162
  article-title: Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model
  publication-title: Cell Death Dis.
– reference: Liu P., Zhao L., Pol J., Levesque S., Petrazzuolo A., Pfirschke C., Engblom C., Rickelt S. Crizotinib-induced immunogenic cell death in non-small cell lung cancer. 2019;10(1):1486.
– year: 2023
  ident: bib185
  article-title: Immunogenic cell death (ICD) enhancers-Drugs that enhance the perception of ICD by dendritic cells
  publication-title: Immunol. Rev.
– volume: 6
  start-page: 29543
  year: 2015
  end-page: 29554
  ident: bib116
  article-title: Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression
  publication-title: Oncotarget
– volume: 11
  start-page: 433
  year: 2020
  ident: bib61
  article-title: Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) in autophagy
  publication-title: Cell Death Dis.
– volume: 5
  year: 2016
  ident: bib195
  article-title: Calreticulin expression: interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer
  publication-title: Oncoimmunology
– volume: 12
  start-page: 4791
  year: 2022
  end-page: 4801
  ident: bib80
  article-title: Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
  publication-title: Theranostics
– volume: 95
  start-page: 127
  year: 2019
  end-page: 135
  ident: bib159
  article-title: Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer
  publication-title: Oral. Oncol.
– volume: 273
  start-page: 33741
  year: 1998
  end-page: 33749
  ident: bib55
  article-title: Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors
  publication-title: J. Biol. Chem.
– volume: 186
  start-page: 1652
  year: 2023
  end-page: 1669
  ident: bib2
  article-title: Immune checkpoint therapy-current perspectives and future directions
  publication-title: Cell
– volume: 7
  year: 2016
  ident: bib91
  article-title: The oncolytic peptide LTX-315 triggers immunogenic cell death
  publication-title: Cell Death Dis.
– volume: 11
  start-page: 6731
  year: 2021
  ident: bib84
  article-title: Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer
  publication-title: Sci. Rep.
– volume: 29
  start-page: 482
  year: 2010
  end-page: 491
  ident: bib158
  article-title: Immunogenic death of colon cancer cells treated with oxaliplatin
  publication-title: Oncogene
– volume: 28
  start-page: 429
  year: 2007
  end-page: 436
  ident: bib35
  article-title: Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox
  publication-title: Trends Immunol.
– volume: 13
  start-page: 5455
  year: 2007
  end-page: 5462
  ident: bib163
  article-title: Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth
  publication-title: Clin. Cancer Res
– volume: 2
  start-page: 468
  year: 2021
  end-page: 483
  ident: bib71
  article-title: Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation
  publication-title: Blood Cancer Discov.
– volume: 20
  start-page: 1941
  year: 2021
  end-page: 1955
  ident: bib95
  article-title: Belantamab mafodotin (GSK2857916) drives immunogenic cell death and immune-mediated antitumor responses in vivo
  publication-title: Mol. Cancer Ther.
– volume: 12
  start-page: 2242211
  year: 2023
  ident: bib187
  article-title: Histamine antagonists promote cancer immunosurveillance
  publication-title: Oncoimmunology
– volume: 18
  start-page: 801
  year: 2013
  end-page: 808
  ident: bib137
  article-title: Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells
  publication-title: Cell Stress Chaperon-.-.
– volume: 12
  year: 2020
  ident: bib63
  article-title: Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
– volume: 11
  start-page: 7
  year: 2023
  ident: bib127
  article-title: Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
  publication-title: J. Immunother. Cancer
– volume: 118
  start-page: 1991
  year: 2008
  end-page: 2001
  ident: bib4
  article-title: The anticancer immune response: indispensable for therapeutic success?
  publication-title: J. Clin. Invest
– volume: 17
  start-page: 389
  year: 2021
  end-page: 399
  ident: bib193
  article-title: Endocrine toxicities of immune checkpoint inhibitors
  publication-title: Nat. Rev. Endocrinol.
– volume: 12
  start-page: 2219591
  year: 2023
  ident: bib9
  article-title: Trial watch: chemotherapy-induced immunogenic cell death in oncology
  publication-title: Oncoimmunology
– volume: 98
  start-page: E65
  year: 2023
  end-page: E67
  ident: bib132
  article-title: Belantamab mafodotin induces immunogenic cell death within 24h post-administration in newly diagnosed multiple myeloma patients
  publication-title: Am. J. Hematol.
– start-page: 11
  year: 2023
  ident: bib111
  article-title: Immunogenic cell death in electroporation-based therapies depends on pulse waveform characteristics
  publication-title: Vaccin. (Basel)
– volume: 16
  start-page: 3100
  year: 2010
  end-page: 3104
  ident: bib53
  article-title: Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway
  publication-title: Clin. Cancer Res
– volume: 72
  start-page: 3013
  year: 2023
  end-page: 3027
  ident: bib197
  article-title: Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
  publication-title: Cancer Immunol. Immunother.
– volume: 15
  start-page: 274
  year: 2016
  end-page: 287
  ident: bib51
  article-title: Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
  publication-title: Cell Rep.
– volume: 7
  start-page: 557
  year: 2021
  end-page: 572
  ident: bib83
  article-title: Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides
  publication-title: Trends Cancer
– volume: 126
  start-page: 1452
  year: 2015
  end-page: 1461
  ident: bib146
  article-title: Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
  publication-title: Blood
– volume: 280
  start-page: 74
  year: 2017
  end-page: 82
  ident: bib34
  article-title: High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair
  publication-title: Immunol. Rev.
– volume: 11
  start-page: 1015
  year: 2020
  ident: bib136
  article-title: Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy
  publication-title: Cell Death Dis.
– volume: 25
  start-page: 271
  year: 1972
  end-page: 280
  ident: bib186
  article-title: A new antibiotic, ikarugamycin
  publication-title: J. Antibiot. (Tokyo)
– volume: 3
  year: 2014
  ident: bib76
  article-title: Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
  publication-title: Oncoimmunology
– year: 2023
  ident: bib46
  article-title: Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 12
  start-page: 15586
  year: 2022
  ident: bib77
  article-title: The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines
  publication-title: Sci. Rep.
– volume: 200
  start-page: 450
  year: 2018
  end-page: 458
  ident: bib14
  article-title: Critical interactions between immunogenic cancer cell death, oncolytic viruses, and the immune system define the rational design of combination immunotherapies
  publication-title: J. Immunol.
– volume: 9
  start-page: 1710398
  year: 2020
  ident: bib128
  article-title: ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer
  publication-title: Oncoimmunology
– volume: 9
  start-page: 4
  year: 2020
  ident: bib166
  article-title: Insights into P-glycoprotein inhibitors: new inducers of immunogenic cell death
  publication-title: Cells
– volume: 8
  start-page: 1
  year: 2020
  ident: bib175
  article-title: Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
  publication-title: J. Immunother. Cancer
– volume: 61
  start-page: 1989
  year: 2012
  end-page: 2002
  ident: bib171
  article-title: Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
  publication-title: Cancer Immunol. Immunother.
– volume: 13
  start-page: 54
  year: 2007
  end-page: 61
  ident: bib22
  article-title: Calreticulin exposure dictates the immunogenicity of cancer cell death
  publication-title: Nat. Med
– volume: 21
  start-page: 1160
  year: 2020
  end-page: 1171
  ident: bib31
  article-title: Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
  publication-title: Nat. Immunol.
– volume: 4
  start-page: 8333
  year: 2021
  end-page: 8342
  ident: bib98
  article-title: Polypeptide-based K(+) ionophore as a strong immunogenic cell death inducer for cancer immunotherapy
  publication-title: ACS Appl. Bio Mater.
– volume: 2
  start-page: 405
  year: 2021
  end-page: 407
  ident: bib72
  article-title: Bortezomib induces immunogenic cell death in multiple myeloma
  publication-title: Blood Cancer Discov.
– volume: 9
  start-page: eadf2746
  year: 2023
  ident: bib119
  article-title: A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response
  publication-title: Sci. Adv.
– volume: 18
  start-page: 2898
  year: 2022
  end-page: 2913
  ident: bib152
  article-title: A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway
  publication-title: Int J. Biol. Sci.
– volume: 20
  start-page: e452
  year: 2019
  end-page: e463
  ident: bib100
  article-title: Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
  publication-title: Lancet Oncol.
– volume: 11
  start-page: 5177
  year: 2023
  end-page: 5185
  ident: bib107
  article-title: NIR-II imaging-guided photothermal cancer therapy combined with enhanced immunogenic death
  publication-title: Biomater. Sci.
– volume: 28
  start-page: 578
  year: 2009
  end-page: 590
  ident: bib39
  article-title: Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
  publication-title: EMBO J.
– volume: 13
  start-page: 1167105
  year: 2023
  ident: bib123
  article-title: Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
  publication-title: Front Oncol.
– volume: 8
  start-page: 2
  year: 2020
  ident: bib160
  article-title: Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer
  publication-title: J. Immunother. Cancer
– volume: 18
  start-page: 3109
  year: 2023
  end-page: 3124
  ident: bib108
  article-title: Multifunctional nanoplatform-mediated chemo-photothermal therapy combines immunogenic cell death with checkpoint blockade to combat triple-negative breast cancer and distant metastasis
  publication-title: Int J. Nanomed.
– volume: 11
  start-page: 2104551
  year: 2022
  ident: bib65
  article-title: Schweinfurthin induces ICD without ER stress and caspase activation
  publication-title: Oncoimmunology
– volume: 42
  year: 2021
  ident: bib129
  article-title: Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer
  publication-title: Redox Biol.
– volume: 7
  start-page: 926
  year: 2008
  end-page: 935
  ident: bib139
  article-title: Novel therapeutic applications of cardiac glycosides
  publication-title: Nat. Rev. Drug Discov.
– volume: 81
  start-page: 1375
  year: 2021
  end-page: 1387
  ident: bib150
  article-title: Enhanced antitumor immunity via endocrine therapy prevents mammary tumor relapse and increases immune checkpoint blockade sensitivity
  publication-title: Cancer Res
– volume: 11
  start-page: 22
  year: 2022
  ident: bib30
  article-title: Tumor immunogenic cell death as a mediator of intratumor CD8 T-cell recruitment
  publication-title: Cells
– volume: 9
  start-page: 436
  year: 2019
  ident: bib156
  article-title: STAT3 contributes to oncolytic newcastle disease virus-induced immunogenic cell death in melanoma cells
  publication-title: Front Oncol.
– volume: 13
  start-page: 183
  year: 2016
  ident: bib192
  article-title: Cardioprotection: cardiotoxicity of anticancer therapy
  publication-title: Nat. Rev. Cardiol.
– volume: 48
  start-page: 1077
  year: 2018
  end-page: 1080
  ident: bib3
  article-title: Immune checkpoint blockade across the cancer care continuum
  publication-title: Immunity
– volume: 12
  start-page: 765
  year: 2016
  end-page: 770
  ident: bib138
  article-title: Capsaicin induces immunogenic cell death in human osteosarcoma cells
  publication-title: Exp. Ther. Med.
– volume: 12
  start-page: 3526
  year: 2021
  ident: bib172
  article-title: Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia
  publication-title: Nat. Commun.
– volume: 4
  year: 2015
  ident: bib125
  article-title: Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
  publication-title: Oncoimmunology
– volume: 31
  start-page: 1062
  year: 2012
  end-page: 1079
  ident: bib56
  article-title: A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
  publication-title: EMBO J.
– volume: 6
  start-page: 129
  year: 2020
  ident: bib135
  article-title: Autophagy-mediated metabolic effects of aspirin
  publication-title: Cell Death Discov.
– volume: 12
  start-page: 314
  year: 2021
  ident: bib75
  article-title: a cardiac glycoside, induces immunogenic cell death via the PERK/elF2alpha/ATF4/CHOP pathway in breast cancer
  publication-title: Cell Death Dis.
– volume: 3
  start-page: 348
  year: 2019
  end-page: 360
  ident: bib86
  article-title: LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects
  publication-title: Cell Stress
– volume: 109
  start-page: 4839
  year: 2007
  end-page: 4845
  ident: bib24
  article-title: Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications
  publication-title: Blood
– volume: 11
  start-page: 2098658
  year: 2022
  ident: bib109
  article-title: A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapy
  publication-title: Oncoimmunology
– volume: 10
  start-page: 4
  year: 2022
  ident: bib114
  article-title: Local anesthetics elicit immune-dependent anticancer effects
  publication-title: J. Immunother. Cancer
– volume: 54
  year: 2022
  ident: bib151
  article-title: Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma
  publication-title: Redox Biol.
– volume: 82
  start-page: 1340
  year: 2022
  end-page: 1352
  ident: bib141
  article-title: CDK4/6 inhibition suppresses p73 phosphorylation and activates DR5 to potentiate chemotherapy and immune checkpoint blockade
  publication-title: Cancer Res
– volume: 9
  start-page: 1196
  year: 2019
  ident: bib144
  article-title: Mitochondria-targeting immunogenic cell death inducer improves the adoptive t-cell therapy against solid tumor
  publication-title: Front Oncol.
– volume: 14
  start-page: 778
  year: 2018
  end-page: 795
  ident: bib50
  article-title: Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance
  publication-title: Autophagy
– volume: 128
  start-page: 3113
  year: 2016
  end-page: 3124
  ident: bib199
  article-title: Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients
  publication-title: Blood
– volume: 37
  start-page: 13
  year: 2018
  ident: bib102
  article-title: Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus
  publication-title: EMBO J.
– volume: 8
  start-page: 1514
  year: 2018
  end-page: 1527
  ident: bib155
  article-title: Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells
  publication-title: Am. J. Cancer Res.
– volume: 3
  start-page: 328
  year: 2019
  end-page: 329
  ident: bib85
  article-title: LTX-315 - a promising novel antitumor peptide and immunotherapeutic agent
  publication-title: Cell Stress
– volume: 6
  year: 2017
  ident: bib90
  article-title: Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
  publication-title: Oncoimmunology
– volume: 48
  start-page: 1915
  year: 2020
  end-page: 1940
  ident: bib133
  article-title: Autophagy Impairment through Lysosome Dysfunction by Brucine Induces Immunogenic Cell Death (ICD)
  publication-title: Am. J. Chin. Med
– volume: 8
  start-page: 2403
  year: 2022
  end-page: 2418
  ident: bib79
  article-title: PAMAM dendritic nanoparticle-incorporated hydrogel to enhance the immunogenic cell death and immune response of immunochemotherapy
  publication-title: ACS Biomater. Sci. Eng.
– volume: 21
  start-page: 645
  year: 2020
  end-page: 654
  ident: bib198
  article-title: Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
  publication-title: Lancet Oncol.
– volume: 8
  year: 2019
  ident: bib149
  article-title: Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
  publication-title: Oncoimmunology
– volume: 8
  start-page: 1596652
  year: 2019
  ident: bib10
  article-title: Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death
  publication-title: Oncoimmunology
– volume: 144
  start-page: 646
  year: 2011
  end-page: 674
  ident: bib1
  article-title: Hallmarks of cancer: the next generation
  publication-title: Cell
– year: . 2019
  ident: bib134
  article-title: 3,4-Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and T
  publication-title: 11(11)
– volume: 7
  start-page: 1776570
  year: 2020
  ident: bib62
  article-title: EIF2alpha phosphorylation: a hallmark of both autophagy and immunogenic cell death
  publication-title: Mol. Cell Oncol.
– volume: 2020
  start-page: 9053274
  year: 2020
  ident: bib115
  article-title: Cordyceps militaris induces immunogenic cell death and enhances antitumor immunogenic response in breast cancer
  publication-title: Evid. Based Complement Altern. Med
– volume: 20
  start-page: 51
  year: 2023
  end-page: 64
  ident: bib126
  article-title: Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis
  publication-title: Cell Mol. Immunol.
– volume: 14
  year: 2022
  ident: bib168
  article-title: PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial Deficiencies
  publication-title: Cancers (Basel)
– year: 2023
  ident: bib121
  article-title: Immunogenic PANoptosis-initiated cancer sono-immune reediting nanotherapy by iteratively boosting cancer immunity cycle
  publication-title: Adv. Mater.
– volume: 172
  start-page: 135
  year: 2022
  end-page: 143
  ident: bib29
  article-title: Assessment of type I interferon responses as a feature of immunogenic cell death
  publication-title: Methods Cell Biol.
– volume: 14
  start-page: 1
  year: 2022
  ident: bib103
  article-title: Induction of immunogenic cell death by photodynamic therapy mediated by aluminum-phthalocyanine in nanoemulsion
  publication-title: Pharmaceutics
– volume: 111
  start-page: 3038
  year: 2022
  end-page: 3046
  ident: bib145
  article-title: Ivermectin enhanced antitumor activity of resiquimod in a co-loaded squalene emulsion
  publication-title: J. Pharm. Sci.
– volume: 152
  start-page: 5398
  year: 1994
  end-page: 5403
  ident: bib23
  article-title: Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70
  publication-title: J. Immunol.
– volume: 20
  start-page: 4
  year: 2019
  ident: bib7
  article-title: Realizing the clinical potential of immunogenic cell death in cancer chemotherapy and radiotherapy
  publication-title: Int J. Mol. Sci.
– volume: 6
  start-page: 26841
  year: 2015
  end-page: 26860
  ident: bib58
  article-title: Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
  publication-title: Oncotarget
– year: 2023
  ident: bib189
  article-title: BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance
  publication-title: Cancer Discov.
– volume: 16
  start-page: 3881
  year: 2022
  end-page: 3894
  ident: bib113
  article-title: Nitric oxide induces immunogenic cell death and potentiates cancer immunotherapy
  publication-title: Cancer Immunol. Immunother.
– volume: 11
  start-page: 7205
  year: 2021
  ident: bib104
  article-title: ovel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death
  publication-title: Sci. Rep.
– volume: 16
  start-page: 9240
  year: 2022
  end-page: 9253
  ident: bib105
  article-title: ER-targeting PDT converts tumors into in situ therapeutic tumor vaccines
  publication-title: ACS Nano
– volume: 334
  start-page: 1573
  year: 2011
  end-page: 1577
  ident: bib20
  article-title: Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice
  publication-title: Science
– volume: 60
  start-page: 2771
  year: 2019
  end-page: 2778
  ident: bib59
  article-title: Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML
  publication-title: Leuk. Lymphoma
– volume: 5
  year: 2016
  ident: bib43
  article-title: Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
  publication-title: Oncoimmunology
– volume: 15
  start-page: 274
  year: 2008
  end-page: 282
  ident: bib37
  article-title: Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin
  publication-title: Cell Death Differ.
– volume: 5
  start-page: 13
  year: 2019
  ident: bib190
  article-title: Radiotherapy toxicity
  publication-title: Nat. Rev. Dis. Prim.
– volume: 350
  start-page: 1
  year: 2020
  end-page: 28
  ident: bib66
  article-title: Endoplasmic reticulum stress in the cellular release of damage-associated molecular patterns
  publication-title: Int Rev. Cell Mol. Biol.
– volume: 99
  start-page: 190
  year: 2002
  end-page: 195
  ident: bib60
  article-title: Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 23
  start-page: 7
  year: 2022
  ident: bib153
  article-title: Norcantharidin induces immunogenic cell death of bladder cancer cells through promoting autophagy in acidic culture
  publication-title: Int J. Mol. Sci.
– volume: 11
  start-page: 408
  year: 2021
  end-page: 423
  ident: bib18
  article-title: A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency
  publication-title: Cancer Discov.
– volume: 12
  start-page: 2174723
  year: 2023
  ident: bib42
  article-title: Arsenic trioxide as an inducer of immunogenic cell death
  publication-title: Oncoimmunology
– volume: 35
  start-page: 5931
  year: 2016
  end-page: 5941
  ident: bib17
  article-title: Damage-associated molecular patterns in cancer: a double-edged sword
  publication-title: Oncogene
– volume: 10
  start-page: 5364
  year: 2022
  end-page: 5374
  ident: bib112
  article-title: Magnetic hyperthermia induces effective and genuine immunogenic tumor cell death with respect to exogenous heating
  publication-title: J. Mater. Chem. B.
– volume: 10
  year: 2023
  ident: bib122
  article-title: Redox-responsive dendrimer nanogels enable ultrasound-enhanced chemoimmunotherapy of pancreatic cancer via endoplasmic reticulum stress amplification and macrophage polarization
  publication-title: Adv. Sci.
– volume: 14
  start-page: 174
  year: 2015
  ident: bib182
  article-title: Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components
  publication-title: Mol. Cancer
– volume: 1
  start-page: 860
  year: 2020
  end-page: 861
  ident: bib110
  article-title: Pseudovirus for immunotherapy
  publication-title: Nat. Cancer
– volume: 10
  start-page: 1973197
  year: 2021
  ident: bib12
  article-title: Crizotinib and ceritinib trigger immunogenic cell death via on-target effects
  publication-title: Oncoimmunology
– volume: 40
  start-page: 2035
  year: 2021
  end-page: 2050
  ident: bib154
  article-title: Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis
  publication-title: Oncogene
– volume: 8
  start-page: 519
  year: 2007
  end-page: 529
  ident: bib52
  article-title: Signal integration in the endoplasmic reticulum unfolded protein response
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 38
  start-page: 729
  year: 2013
  end-page: 741
  ident: bib28
  article-title: Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells
  publication-title: Immunity
– volume: 301
  year: 2023
  ident: bib120
  article-title: Focused acoustic vortex-mediated sonochemotherapy for the amplification of immunogenic cell death combined with checkpoint blockade to potentiate cancer immunotherapy
  publication-title: Biomaterials
– volume: 153
  start-page: 12
  year: 2018
  end-page: 23
  ident: bib16
  article-title: Stress-induced cellular responses in immunogenic cell death: implications for cancer immunotherapy
  publication-title: Biochem Pharm.
– volume: 13
  year: 2022
  ident: bib142
  article-title: Chromomycin A(5) induces bona fide immunogenic cell death in melanoma
  publication-title: Front Immunol.
– volume: 57
  start-page: 903
  year: 2018
  end-page: 910
  ident: bib148
  article-title: Treatment of colon cancer with liver X receptor agonists induces immunogenic cell death
  publication-title: Mol. Carcinog.
– volume: 11
  start-page: 6299
  year: 2020
  ident: bib33
  article-title: Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
  publication-title: Nat. Commun.
– volume: 4
  start-page: 143ra99
  year: 2012
  ident: bib73
  article-title: Cardiac glycosides exert anticancer effects by inducing immunogenic cell death
  publication-title: Sci. Transl. Med
– volume: 12
  year: 2020
  ident: bib170
  article-title: Rafoxanide induces immunogenic death of colorectal cancer cells
  publication-title: Cancers
– volume: 17
  year: 2022
  ident: bib143
  article-title: Enhancement of CD8(+) T-cell-mediated tumor immunotherapy via magnetic hyperthermia
  publication-title: ChemMedChem
– volume: 110
  start-page: 256
  year: 2019
  end-page: 268
  ident: bib165
  article-title: CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells
  publication-title: Cancer Sci.
– volume: 26
  start-page: 2
  year: 2021
  ident: bib118
  article-title: Arginine deiminase induces immunogenic cell death and is enhanced by N-acetylcysteine in murine MC38 colorectal cancer cells and MDA-MB-231 human breast cancer cells in vitro
  publication-title: Molecules
– volume: 13
  year: 2022
  ident: bib180
  article-title: Autophagy activation by dietary piceatannol enhances the efficacy of immunogenic chemotherapy
  publication-title: Front Immunol.
– volume: 11
  start-page: 2068109
  year: 2022
  ident: bib124
  article-title: Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade
  publication-title: Oncoimmunology
– volume: 20
  start-page: 1301
  year: 2014
  end-page: 1309
  ident: bib27
  article-title: Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
  publication-title: Nat. Med
– volume: 33
  start-page: 86
  year: 2015
  end-page: 92
  ident: bib57
  article-title: eIF2alpha phosphorylation as a biomarker of immunogenic cell death
  publication-title: Semin Cancer Biol.
– volume: 9
  start-page: 1086
  year: 2018
  ident: bib89
  article-title: Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals
  publication-title: Cell Death Dis.
– volume: 8
  start-page: 2
  year: 2020
  ident: bib49
  article-title: Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
  publication-title: J. Immunother. Cancer
– volume: 7
  year: 2018
  ident: bib32
  article-title: TFAM is a novel mediator of immunogenic cancer cell death
  publication-title: Oncoimmunology
– volume: 21
  start-page: 162
  year: 2023
  ident: bib40
  article-title: Immunogenic cell death in cancer: concept and therapeutic implications
  publication-title: J. Transl. Med
– volume: 14
  start-page: 139
  year: 2019
  end-page: 148
  ident: bib87
  article-title: The novel oncolytic compound LTX-401 induces antitumor immune responses in experimental hepatocellular carcinoma
  publication-title: Mol. Ther. Oncolytics
– volume: 39
  start-page: 208
  year: 2019
  end-page: 214
  ident: bib157
  article-title: Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma
  publication-title: J. Recept Signal Transduct. Res
– volume: 49
  year: 2022
  ident: bib167
  article-title: Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours
  publication-title: EClinicalMedicine
– volume: 20
  start-page: 116
  year: 2023
  end-page: 134
  ident: bib117
  article-title: Thermal immuno-nanomedicine in cancer
  publication-title: Nat. Rev. Clin. Oncol.
– volume: 4
  issue: 4
  year: 2015
  ident: 10.1016/j.semcdb.2023.10.007_bib125
  article-title: Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2015.1008866
– start-page: 11
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib111
  article-title: Immunogenic cell death in electroporation-based therapies depends on pulse waveform characteristics
  publication-title: Vaccin. (Basel)
– volume: 110
  start-page: 256
  issue: 1
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib165
  article-title: CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells
  publication-title: Cancer Sci.
  doi: 10.1111/cas.13885
– volume: 28
  start-page: 578
  issue: 5
  year: 2009
  ident: 10.1016/j.semcdb.2023.10.007_bib39
  article-title: Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
  publication-title: EMBO J.
  doi: 10.1038/emboj.2009.1
– volume: 8
  start-page: 2
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib49
  article-title: Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
  publication-title: J. Immunother. Cancer
  doi: 10.1136/jitc-2020-001369
– volume: 7
  issue: 6
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib32
  article-title: TFAM is a novel mediator of immunogenic cancer cell death
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2018.1431086
– volume: 57
  start-page: 903
  issue: 7
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib148
  article-title: Treatment of colon cancer with liver X receptor agonists induces immunogenic cell death
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.22811
– volume: 12
  start-page: 2174723
  issue: 1
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib42
  article-title: Arsenic trioxide as an inducer of immunogenic cell death
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2023.2174723
– volume: 9
  start-page: 436
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib156
  article-title: STAT3 contributes to oncolytic newcastle disease virus-induced immunogenic cell death in melanoma cells
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2019.00436
– year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib121
  article-title: Immunogenic PANoptosis-initiated cancer sono-immune reediting nanotherapy by iteratively boosting cancer immunity cycle
  publication-title: Adv. Mater.
– volume: 12
  start-page: 2242211
  issue: 1
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib187
  article-title: Histamine antagonists promote cancer immunosurveillance
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2023.2242211
– volume: 74
  start-page: 640
  issue: 2
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib147
  article-title: Immunogenic Cell Death (ICD) of Murine H22 Cells Induced by Lentinan
  publication-title: Nutr. Cancer
  doi: 10.1080/01635581.2021.1897632
– volume: 15
  start-page: 1499
  issue: 9
  year: 2008
  ident: 10.1016/j.semcdb.2023.10.007_bib38
  article-title: The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2008.67
– volume: 13
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib180
  article-title: Autophagy activation by dietary piceatannol enhances the efficacy of immunogenic chemotherapy
  publication-title: Front Immunol.
– volume: 17
  start-page: 49
  issue: 1
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib92
  article-title: Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-019-0272-7
– volume: 12
  issue: 5
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib170
  article-title: Rafoxanide induces immunogenic death of colorectal cancer cells
  publication-title: Cancers
  doi: 10.3390/cancers12051314
– volume: 35
  start-page: 5931
  issue: 46
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib17
  article-title: Damage-associated molecular patterns in cancer: a double-edged sword
  publication-title: Oncogene
  doi: 10.1038/onc.2016.104
– volume: 16
  start-page: 9240
  issue: 6
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib105
  article-title: ER-targeting PDT converts tumors into in situ therapeutic tumor vaccines
  publication-title: ACS Nano
  doi: 10.1021/acsnano.2c01669
– volume: 14
  start-page: 1
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib103
  article-title: Induction of immunogenic cell death by photodynamic therapy mediated by aluminum-phthalocyanine in nanoemulsion
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics14010196
– volume: 6
  issue: 8
  year: 2017
  ident: 10.1016/j.semcdb.2023.10.007_bib90
  article-title: Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2017.1338236
– volume: 12
  start-page: 314
  issue: 4
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib75
  article-title: a cardiac glycoside, induces immunogenic cell death via the PERK/elF2alpha/ATF4/CHOP pathway in breast cancer
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-021-03605-y
– volume: 111
  start-page: 3038
  issue: 11
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib145
  article-title: Ivermectin enhanced antitumor activity of resiquimod in a co-loaded squalene emulsion
  publication-title: J. Pharm. Sci.
  doi: 10.1016/j.xphs.2022.06.005
– volume: 162
  start-page: 842
  issue: 6
  year: 2013
  ident: 10.1016/j.semcdb.2023.10.007_bib96
  article-title: The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab
  publication-title: Br. J. Haematol.
  doi: 10.1111/bjh.12427
– volume: 334
  start-page: 1573
  issue: 6062
  year: 2011
  ident: 10.1016/j.semcdb.2023.10.007_bib20
  article-title: Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice
  publication-title: Science
  doi: 10.1126/science.1208347
– volume: 10
  issue: 11
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib174
  article-title: SS1P immunotoxin induces markers of immunogenic cell death and enhances the effect of the CTLA-4 BLOCKADe in AE17M mouse mesothelioma tumors
  publication-title: Toxins
  doi: 10.3390/toxins10110470
– volume: 8
  start-page: 1099
  issue: 8
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib68
  article-title: Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4/IKK2/SNARE-dependent exocytosis
  publication-title: Cancer Immunol. Res
  doi: 10.1158/2326-6066.CIR-19-0616
– volume: 12
  start-page: 765
  issue: 2
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib138
  article-title: Capsaicin induces immunogenic cell death in human osteosarcoma cells
  publication-title: Exp. Ther. Med.
  doi: 10.3892/etm.2016.3368
– volume: 49
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib167
  article-title: Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2022.101430
– volume: 12
  start-page: 2219591
  issue: 1
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib9
  article-title: Trial watch: chemotherapy-induced immunogenic cell death in oncology
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2023.2219591
– volume: 2
  start-page: 405
  issue: 5
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib72
  article-title: Bortezomib induces immunogenic cell death in multiple myeloma
  publication-title: Blood Cancer Discov.
  doi: 10.1158/2643-3230.BCD-21-0059
– volume: 14
  start-page: 174
  year: 2015
  ident: 10.1016/j.semcdb.2023.10.007_bib182
  article-title: Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-015-0435-9
– volume: 128
  start-page: 3113
  issue: 26
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib199
  article-title: Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients
  publication-title: Blood
  doi: 10.1182/blood-2016-08-731737
– volume: 33
  start-page: 86
  year: 2015
  ident: 10.1016/j.semcdb.2023.10.007_bib57
  article-title: eIF2alpha phosphorylation as a biomarker of immunogenic cell death
  publication-title: Semin Cancer Biol.
  doi: 10.1016/j.semcancer.2015.02.004
– volume: 11
  start-page: 6731
  issue: 1
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib84
  article-title: Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-86239-6
– volume: 3
  year: 2014
  ident: 10.1016/j.semcdb.2023.10.007_bib76
  article-title: Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
  publication-title: Oncoimmunology
  doi: 10.4161/onci.28473
– volume: 54
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib151
  article-title: Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2022.102351
– volume: 13
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib142
  article-title: Chromomycin A(5) induces bona fide immunogenic cell death in melanoma
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2022.941757
– volume: 12
  start-page: 4791
  issue: 10
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib80
  article-title: Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
  publication-title: Theranostics
  doi: 10.7150/thno.69168
– volume: 10
  start-page: 1996686
  issue: 1
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib6
  article-title: Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2021.1996686
– volume: 15
  start-page: 274
  issue: 2
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib51
  article-title: Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2016.03.037
– volume: 6
  start-page: 29543
  issue: 30
  year: 2015
  ident: 10.1016/j.semcdb.2023.10.007_bib116
  article-title: Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.4911
– volume: 10
  start-page: 1973197
  issue: 1
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib12
  article-title: Crizotinib and ceritinib trigger immunogenic cell death via on-target effects
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2021.1973197
– volume: 10
  start-page: 1962592
  issue: 1
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib82
  article-title: LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2021.1962592
– volume: 12
  start-page: 2271693
  issue: 1
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib188
  article-title: A mitochondrial checkpoint to adaptive anticancer immunity
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2023.2271693
– volume: 12
  start-page: 1962
  issue: 10
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib179
  article-title: Autophagy induction for the treatment of cancer
  publication-title: Autophagy
  doi: 10.1080/15548627.2016.1214778
– volume: 9
  start-page: 1086
  issue: 11
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib89
  article-title: Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-018-1127-3
– volume: 140
  start-page: 1771
  issue: 9
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib97
  article-title: Imiquimod exerts antitumor effects by inducing immunogenic cell death and is enhanced by the glycolytic inhibitor 2-deoxyglucose
  publication-title: J. Invest Dermatol.
  doi: 10.1016/j.jid.2019.12.039
– volume: 12
  issue: 5
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib63
  article-title: Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
– volume: 18
  start-page: 2898
  issue: 7
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib152
  article-title: A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway
  publication-title: Int J. Biol. Sci.
  doi: 10.7150/ijbs.70975
– volume: 7
  start-page: 557
  issue: 6
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib83
  article-title: Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2020.12.012
– volume: 87
  start-page: 425
  issue: 3
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib164
  article-title: Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8(+) T cell augmentation
  publication-title: Cancer Chemother. Pharm.
  doi: 10.1007/s00280-020-04209-7
– volume: 15
  start-page: 3
  issue: 1
  year: 2008
  ident: 10.1016/j.semcdb.2023.10.007_bib36
  article-title: Molecular characteristics of immunogenic cancer cell death
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4402269
– volume: 10
  start-page: 4
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib114
  article-title: Local anesthetics elicit immune-dependent anticancer effects
  publication-title: J. Immunother. Cancer
  doi: 10.1136/jitc-2021-004151
– volume: 7
  issue: 3
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib91
  article-title: The oncolytic peptide LTX-315 triggers immunogenic cell death
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2016.47
– volume: 9
  start-page: 353
  issue: 5
  year: 2009
  ident: 10.1016/j.semcdb.2023.10.007_bib8
  article-title: Immunogenic and tolerogenic cell death
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2545
– volume: 30
  start-page: 147
  issue: 1
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib178
  article-title: Caloric restriction mimetics enhance anticancer immunosurveillance
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.05.016
– volume: 16
  start-page: 15471
  issue: 9
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib184
  article-title: Immunogenic cell death augmented by manganese zinc sulfide nanoparticles for metastatic melanoma immunotherapy
  publication-title: ACS Nano
  doi: 10.1021/acsnano.2c08013
– volume: 11
  start-page: 1015
  issue: 11
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib136
  article-title: Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-020-03226-x
– volume: 72
  start-page: 3013
  issue: 9
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib197
  article-title: Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-023-03470-y
– volume: 21
  start-page: 1160
  issue: 10
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib31
  article-title: Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-020-0751-0
– volume: 5
  issue: 6
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib43
  article-title: Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2016.1149673
– volume: 20
  start-page: 1941
  issue: 10
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib95
  article-title: Belantamab mafodotin (GSK2857916) drives immunogenic cell death and immune-mediated antitumor responses in vivo
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-21-0035
– volume: 11
  start-page: 6299
  issue: 1
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib33
  article-title: Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19970-9
– year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib101
  article-title: Molecular determinants of immunogenic cell death elicited by radiation therapy
  publication-title: Immunol. Rev.
– volume: 11
  start-page: 2098658
  issue: 1
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib109
  article-title: A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapy
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2022.2098658
– year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib189
  article-title: BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-22-1338
– volume: 31
  start-page: 1087
  issue: 4
  year: 2013
  ident: 10.1016/j.semcdb.2023.10.007_bib140
  article-title: Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials
  publication-title: Investig. N. Drugs
  doi: 10.1007/s10637-013-9984-1
– volume: 8
  start-page: 1596652
  issue: 7
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib10
  article-title: Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2019.1596652
– year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib78
  article-title: Local drug delivery techniques for triggering immunogenic cell death
  publication-title: Small Methods
  doi: 10.1002/smtd.202300347
– volume: 21
  start-page: 645
  issue: 5
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib198
  article-title: Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(20)30068-1
– volume: 172
  start-page: 135
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib29
  article-title: Assessment of type I interferon responses as a feature of immunogenic cell death
  publication-title: Methods Cell Biol.
  doi: 10.1016/bs.mcb.2021.12.028
– volume: 7
  start-page: 1776570
  issue: 5
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib62
  article-title: EIF2alpha phosphorylation: a hallmark of both autophagy and immunogenic cell death
  publication-title: Mol. Cell Oncol.
  doi: 10.1080/23723556.2020.1776570
– volume: 18
  start-page: 3109
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib108
  article-title: Multifunctional nanoplatform-mediated chemo-photothermal therapy combines immunogenic cell death with checkpoint blockade to combat triple-negative breast cancer and distant metastasis
  publication-title: Int J. Nanomed.
  doi: 10.2147/IJN.S408855
– volume: 16
  start-page: 3881
  issue: 3
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib113
  article-title: Nitric oxide induces immunogenic cell death and potentiates cancer immunotherapy
  publication-title: Cancer Immunol. Immunother.
– volume: 41
  start-page: 1014
  issue: 6
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib21
  article-title: Calreticulin exposure orchestrates innate immunosurveillance
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2023.04.015
– volume: 10
  start-page: 1862949
  issue: 1
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib48
  article-title: Ferroptosis becomes immunogenic: implications for anticancer treatments
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2020.1862949
– year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib46
  article-title: Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/s41580-023-00623-w
– volume: 42
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib129
  article-title: Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2021.101949
– volume: 29
  start-page: 482
  issue: 4
  year: 2010
  ident: 10.1016/j.semcdb.2023.10.007_bib158
  article-title: Immunogenic death of colon cancer cells treated with oxaliplatin
  publication-title: Oncogene
  doi: 10.1038/onc.2009.356
– volume: 17
  issue: 2
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib143
  article-title: Enhancement of CD8(+) T-cell-mediated tumor immunotherapy via magnetic hyperthermia
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.202100656
– volume: 8
  start-page: 2403
  issue: 6
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib79
  article-title: PAMAM dendritic nanoparticle-incorporated hydrogel to enhance the immunogenic cell death and immune response of immunochemotherapy
  publication-title: ACS Biomater. Sci. Eng.
  doi: 10.1021/acsbiomaterials.2c00171
– volume: 19
  issue: 32
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib106
  article-title: Molecular engineering of NIR-II/IIb emitting AIEgen for multimodal imaging-guided photo-immunotherapy
  publication-title: Small
  doi: 10.1002/smll.202300859
– volume: 13
  start-page: 1050
  issue: 9
  year: 2007
  ident: 10.1016/j.semcdb.2023.10.007_bib26
  article-title: Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
  publication-title: Nat. Med
  doi: 10.1038/nm1622
– volume: 202
  start-page: 1691
  issue: 12
  year: 2005
  ident: 10.1016/j.semcdb.2023.10.007_bib67
  article-title: Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
  publication-title: J. Exp. Med
  doi: 10.1084/jem.20050915
– volume: 8
  start-page: 1606665
  issue: 8
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib74
  article-title: A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2019.1606665
– volume: 109
  start-page: 4839
  issue: 11
  year: 2007
  ident: 10.1016/j.semcdb.2023.10.007_bib24
  article-title: Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications
  publication-title: Blood
  doi: 10.1182/blood-2006-10-054221
– volume: 12
  start-page: 15586
  issue: 1
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib77
  article-title: The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-19597-4
– volume: 13
  issue: 8
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib176
  article-title: A novel thienopyrimidine analog, TPH104, mediates immunogenic cell death in triple-negative breast cancer cells
  publication-title: Cancers
  doi: 10.3390/cancers13081954
– volume: 37
  start-page: 13
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib102
  article-title: Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus
  publication-title: EMBO J.
  doi: 10.15252/embj.201798354
– volume: 200
  start-page: 450
  issue: 2
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib14
  article-title: Critical interactions between immunogenic cancer cell death, oncolytic viruses, and the immune system define the rational design of combination immunotherapies
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1701021
– volume: 11
  start-page: 2127273
  issue: 1
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib45
  article-title: Is ferroptosis immunogenic? The devil is in the details!
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2022.2127273
– volume: 278
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib44
  article-title: Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2021.121167
– volume: 186
  start-page: 1652
  issue: 8
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib2
  article-title: Immune checkpoint therapy-current perspectives and future directions
  publication-title: Cell
  doi: 10.1016/j.cell.2023.03.006
– volume: 8
  start-page: 1594555
  issue: 7
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib88
  article-title: Tumor lysis with LTX-401 creates anticancer immunity
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2019.1594555
– volume: 26
  start-page: 2
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib118
  article-title: Arginine deiminase induces immunogenic cell death and is enhanced by N-acetylcysteine in murine MC38 colorectal cancer cells and MDA-MB-231 human breast cancer cells in vitro
  publication-title: Molecules
– volume: 5
  issue: 7
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib195
  article-title: Calreticulin expression: interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2016.1177692
– volume: 12
  start-page: 3526
  issue: 1
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib172
  article-title: Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-23752-2
– volume: 11
  start-page: 2068109
  issue: 1
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib124
  article-title: Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2022.2068109
– volume: 14
  issue: 16
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib168
  article-title: PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial Deficiencies
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers14163851
– volume: 82
  start-page: 1340
  issue: 7
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib141
  article-title: CDK4/6 inhibition suppresses p73 phosphorylation and activates DR5 to potentiate chemotherapy and immune checkpoint blockade
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-21-3062
– volume: 88
  start-page: 5263
  issue: 10
  year: 2014
  ident: 10.1016/j.semcdb.2023.10.007_bib93
  article-title: Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer
  publication-title: J. Virol.
  doi: 10.1128/JVI.03688-13
– volume: 20
  start-page: 116
  issue: 2
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib117
  article-title: Thermal immuno-nanomedicine in cancer
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-022-00717-y
– volume: 95
  start-page: 127
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib159
  article-title: Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer
  publication-title: Oral. Oncol.
  doi: 10.1016/j.oraloncology.2019.06.016
– volume: 8
  start-page: 519
  issue: 7
  year: 2007
  ident: 10.1016/j.semcdb.2023.10.007_bib52
  article-title: Signal integration in the endoplasmic reticulum unfolded protein response
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm2199
– volume: 2
  start-page: 468
  issue: 5
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib71
  article-title: Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation
  publication-title: Blood Cancer Discov.
  doi: 10.1158/2643-3230.BCD-21-0047
– volume: 10
  issue: 24
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib122
  article-title: Redox-responsive dendrimer nanogels enable ultrasound-enhanced chemoimmunotherapy of pancreatic cancer via endoplasmic reticulum stress amplification and macrophage polarization
  publication-title: Adv. Sci.
  doi: 10.1002/advs.202301759
– volume: 280
  start-page: 74
  issue: 1
  year: 2017
  ident: 10.1016/j.semcdb.2023.10.007_bib34
  article-title: High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair
  publication-title: Immunol. Rev.
  doi: 10.1111/imr.12601
– volume: 14
  start-page: 1848
  issue: 10
  year: 2007
  ident: 10.1016/j.semcdb.2023.10.007_bib99
  article-title: Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4402201
– volume: 6
  start-page: 38
  issue: 1
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib194
  article-title: Immune-related adverse events of checkpoint inhibitors
  publication-title: Nat. Rev. Dis. Prim.
  doi: 10.1038/s41572-020-0160-6
– volume: 6
  start-page: 26841
  issue: 29
  year: 2015
  ident: 10.1016/j.semcdb.2023.10.007_bib58
  article-title: Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.4754
– volume: 11
  start-page: 109
  issue: 2
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib177
  article-title: Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-020-2304-8
– volume: 14
  start-page: 778
  issue: 5
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib50
  article-title: Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance
  publication-title: Autophagy
  doi: 10.1080/15548627.2017.1386359
– volume: 8
  start-page: 1514
  issue: 8
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib155
  article-title: Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells
  publication-title: Am. J. Cancer Res.
– volume: 25
  start-page: 875
  issue: 11–12
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib161
  article-title: The delay in cell death caused by the induction of autophagy by P2Et extract is essential for the generation of immunogenic signals in melanoma cells
  publication-title: Apoptosis
  doi: 10.1007/s10495-020-01643-z
– volume: 13
  start-page: 183
  issue: 4
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib192
  article-title: Cardioprotection: cardiotoxicity of anticancer therapy
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/nrcardio.2016.39
– volume: 7
  start-page: 926
  issue: 11
  year: 2008
  ident: 10.1016/j.semcdb.2023.10.007_bib139
  article-title: Novel therapeutic applications of cardiac glycosides
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2682
– volume: 13
  start-page: 410
  issue: 2
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib47
  article-title: Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-22-0523
– volume: 14
  start-page: 139
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib87
  article-title: The novel oncolytic compound LTX-401 induces antitumor immune responses in experimental hepatocellular carcinoma
  publication-title: Mol. Ther. Oncolytics
  doi: 10.1016/j.omto.2019.05.002
– volume: 118
  start-page: 1991
  issue: 6
  year: 2008
  ident: 10.1016/j.semcdb.2023.10.007_bib4
  article-title: The anticancer immune response: indispensable for therapeutic success?
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI35180
– volume: 418
  start-page: 191
  issue: 6894
  year: 2002
  ident: 10.1016/j.semcdb.2023.10.007_bib25
  article-title: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
  publication-title: Nature
  doi: 10.1038/nature00858
– volume: 25
  start-page: 271
  issue: 5
  year: 1972
  ident: 10.1016/j.semcdb.2023.10.007_bib186
  article-title: A new antibiotic, ikarugamycin
  publication-title: J. Antibiot. (Tokyo)
  doi: 10.7164/antibiotics.25.271
– volume: 11
  start-page: 9470
  issue: 19
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib81
  article-title: Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem
  publication-title: Theranostics
  doi: 10.7150/thno.62984
– volume: 40
  start-page: 2035
  issue: 11
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib154
  article-title: Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis
  publication-title: Oncogene
  doi: 10.1038/s41388-021-01687-8
– volume: 11
  start-page: 22
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib30
  article-title: Tumor immunogenic cell death as a mediator of intratumor CD8 T-cell recruitment
  publication-title: Cells
  doi: 10.3390/cells11223672
– volume: 13
  start-page: 5455
  issue: 18 Pt 1
  year: 2007
  ident: 10.1016/j.semcdb.2023.10.007_bib163
  article-title: Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth
  publication-title: Clin. Cancer Res
  doi: 10.1158/1078-0432.CCR-07-0517
– volume: 11
  start-page: 408
  issue: 2
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib18
  article-title: A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-20-0465
– volume: 8
  start-page: 328ra27
  issue: 328
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib13
  article-title: Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
  publication-title: Sci. Transl. Med
  doi: 10.1126/scitranslmed.aae0105
– volume: 152
  start-page: 5398
  issue: 11
  year: 1994
  ident: 10.1016/j.semcdb.2023.10.007_bib23
  article-title: Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.152.11.5398
– volume: 8
  start-page: 2
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib160
  article-title: Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer
  publication-title: J. Immunother. Cancer
  doi: 10.1136/jitc-2020-001714
– volume: 61
  start-page: 1989
  issue: 11
  year: 2012
  ident: 10.1016/j.semcdb.2023.10.007_bib171
  article-title: Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-012-1258-9
– volume: 2020
  start-page: 9053274
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib115
  article-title: Cordyceps militaris induces immunogenic cell death and enhances antitumor immunogenic response in breast cancer
  publication-title: Evid. Based Complement Altern. Med
  doi: 10.1155/2020/9053274
– volume: 153
  start-page: 12
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib16
  article-title: Stress-induced cellular responses in immunogenic cell death: implications for cancer immunotherapy
  publication-title: Biochem Pharm.
  doi: 10.1016/j.bcp.2018.02.006
– volume: 21
  start-page: 162
  issue: 1
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib40
  article-title: Immunogenic cell death in cancer: concept and therapeutic implications
  publication-title: J. Transl. Med
  doi: 10.1186/s12967-023-04017-6
– volume: 1
  issue: 12
  year: 2010
  ident: 10.1016/j.semcdb.2023.10.007_bib64
  article-title: Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2010.82
– volume: 3
  start-page: 348
  issue: 11
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib86
  article-title: LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects
  publication-title: Cell Stress
  doi: 10.15698/cst2019.11.204
– volume: 17
  start-page: 474
  issue: 8
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib191
  article-title: Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/s41569-020-0348-1
– volume: 11
  start-page: 2104551
  issue: 1
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib65
  article-title: Schweinfurthin induces ICD without ER stress and caspase activation
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2022.2104551
– volume: 69
  start-page: 1
  issue: 1
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib54
  article-title: Glutamate Dehydrogenase to the Rescue
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2017.12.015
– volume: 126
  start-page: 1452
  issue: 12
  year: 2015
  ident: 10.1016/j.semcdb.2023.10.007_bib146
  article-title: Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood-2015-02-630335
– volume: 48
  start-page: 1915
  issue: 8
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib133
  article-title: Autophagy Impairment through Lysosome Dysfunction by Brucine Induces Immunogenic Cell Death (ICD)
  publication-title: Am. J. Chin. Med
  doi: 10.1142/S0192415X20500962
– volume: 9
  start-page: 1710398
  issue: 1
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib128
  article-title: ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2019.1710398
– year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib134
  article-title: 3,4-Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and T
  publication-title: 11(11)
– volume: 98
  start-page: E65
  issue: 3
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib132
  article-title: Belantamab mafodotin induces immunogenic cell death within 24h post-administration in newly diagnosed multiple myeloma patients
  publication-title: Am. J. Hematol.
  doi: 10.1002/ajh.26823
– volume: 350
  start-page: 1
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib66
  article-title: Endoplasmic reticulum stress in the cellular release of damage-associated molecular patterns
  publication-title: Int Rev. Cell Mol. Biol.
  doi: 10.1016/bs.ircmb.2019.11.006
– volume: 6
  start-page: 129
  issue: 1
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib135
  article-title: Autophagy-mediated metabolic effects of aspirin
  publication-title: Cell Death Discov.
  doi: 10.1038/s41420-020-00365-0
– volume: 13
  start-page: 1167105
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib123
  article-title: Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2023.1167105
– volume: 4
  start-page: 8333
  issue: 12
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib98
  article-title: Polypeptide-based K(+) ionophore as a strong immunogenic cell death inducer for cancer immunotherapy
  publication-title: ACS Appl. Bio Mater.
  doi: 10.1021/acsabm.1c00861
– volume: 3
  start-page: 328
  issue: 11
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib85
  article-title: LTX-315 - a promising novel antitumor peptide and immunotherapeutic agent
  publication-title: Cell Stress
  doi: 10.15698/cst2019.11.202
– volume: 11
  start-page: 5177
  issue: 15
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib107
  article-title: NIR-II imaging-guided photothermal cancer therapy combined with enhanced immunogenic death
  publication-title: Biomater. Sci.
  doi: 10.1039/D3BM00700F
– volume: 48
  start-page: 1077
  issue: 6
  year: 2018
  ident: 10.1016/j.semcdb.2023.10.007_bib3
  article-title: Immune checkpoint blockade across the cancer care continuum
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.06.003
– volume: 301
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib120
  article-title: Focused acoustic vortex-mediated sonochemotherapy for the amplification of immunogenic cell death combined with checkpoint blockade to potentiate cancer immunotherapy
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2023.122278
– volume: 20
  start-page: 1301
  issue: 11
  year: 2014
  ident: 10.1016/j.semcdb.2023.10.007_bib27
  article-title: Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
  publication-title: Nat. Med
  doi: 10.1038/nm.3708
– volume: 99
  start-page: 190
  issue: 1
  year: 2002
  ident: 10.1016/j.semcdb.2023.10.007_bib60
  article-title: Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.012485299
– volume: 17
  start-page: 389
  issue: 7
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib193
  article-title: Endocrine toxicities of immune checkpoint inhibitors
  publication-title: Nat. Rev. Endocrinol.
  doi: 10.1038/s41574-021-00484-3
– volume: 337
  start-page: 1678
  issue: 6102
  year: 2012
  ident: 10.1016/j.semcdb.2023.10.007_bib69
  article-title: An immunosurveillance mechanism controls cancer cell ploidy
  publication-title: Science
  doi: 10.1126/science.1224922
– volume: 15
  start-page: 973
  issue: 6
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib131
  article-title: AXL targeting abrogates autophagic flux and induces immunogenic cell death in drug-resistant cancer cells
  publication-title: J. Thorac. Oncol.
  doi: 10.1016/j.jtho.2020.01.015
– volume: 18
  start-page: 801
  issue: 6
  year: 2013
  ident: 10.1016/j.semcdb.2023.10.007_bib137
  article-title: Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells
  publication-title: Cell Stress Chaperon-.-.
  doi: 10.1007/s12192-013-0422-2
– volume: 4
  start-page: 143ra99
  issue: 143
  year: 2012
  ident: 10.1016/j.semcdb.2023.10.007_bib73
  article-title: Cardiac glycosides exert anticancer effects by inducing immunogenic cell death
  publication-title: Sci. Transl. Med
  doi: 10.1126/scitranslmed.3003807
– volume: 13
  start-page: 54
  issue: 1
  year: 2007
  ident: 10.1016/j.semcdb.2023.10.007_bib22
  article-title: Calreticulin exposure dictates the immunogenicity of cancer cell death
  publication-title: Nat. Med
  doi: 10.1038/nm1523
– volume: 392
  start-page: 86
  issue: 6671
  year: 1998
  ident: 10.1016/j.semcdb.2023.10.007_bib41
  article-title: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
  publication-title: Nature
  doi: 10.1038/32183
– volume: 11
  start-page: 7205
  issue: 1
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib104
  article-title: ovel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-86354-4
– volume: 28
  start-page: 429
  issue: 10
  year: 2007
  ident: 10.1016/j.semcdb.2023.10.007_bib35
  article-title: Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2007.08.004
– volume: 9
  start-page: 4
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib166
  article-title: Insights into P-glycoprotein inhibitors: new inducers of immunogenic cell death
  publication-title: Cells
  doi: 10.3390/cells9041033
– volume: 16
  start-page: 1166
  issue: 6
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib181
  article-title: Autophagy induction by thiostrepton for the improvement of anticancer therapy
  publication-title: Autophagy
  doi: 10.1080/15548627.2020.1758417
– volume: 3
  issue: 9
  year: 2014
  ident: 10.1016/j.semcdb.2023.10.007_bib15
  article-title: Consensus guidelines for the detection of immunogenic cell death
  publication-title: Oncoimmunology
  doi: 10.4161/21624011.2014.955691
– volume: 11
  start-page: 433
  issue: 6
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib61
  article-title: Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) in autophagy
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-020-2642-6
– volume: 16
  start-page: 3100
  issue: 12
  year: 2010
  ident: 10.1016/j.semcdb.2023.10.007_bib53
  article-title: Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway
  publication-title: Clin. Cancer Res
  doi: 10.1158/1078-0432.CCR-09-2891
– volume: 144
  start-page: 646
  issue: 5
  year: 2011
  ident: 10.1016/j.semcdb.2023.10.007_bib1
  article-title: Hallmarks of cancer: the next generation
  publication-title: Cell
  doi: 10.1016/j.cell.2011.02.013
– volume: 29
  start-page: 1310
  issue: 6
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib5
  article-title: Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
  publication-title: Nat. Med
  doi: 10.1038/s41591-023-02336-1
– volume: 8
  start-page: 1
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib175
  article-title: Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
  publication-title: J. Immunother. Cancer
  doi: 10.1136/jitc-2019-000462
– volume: 10
  start-page: 5364
  issue: 28
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib112
  article-title: Magnetic hyperthermia induces effective and genuine immunogenic tumor cell death with respect to exogenous heating
  publication-title: J. Mater. Chem. B.
  doi: 10.1039/D2TB01004F
– volume: 12
  start-page: 713
  issue: 8
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib183
  article-title: Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-021-03997-x
– volume: 21
  start-page: 207
  issue: 2
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib94
  article-title: Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(19)30788-0
– volume: 1
  start-page: 860
  issue: 9
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib110
  article-title: Pseudovirus for immunotherapy
  publication-title: Nat. Cancer
  doi: 10.1038/s43018-020-00107-2
– volume: 5
  start-page: 13
  issue: 1
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib190
  article-title: Radiotherapy toxicity
  publication-title: Nat. Rev. Dis. Prim.
  doi: 10.1038/s41572-019-0064-5
– volume: 60
  start-page: 2771
  issue: 11
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib59
  article-title: Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML
  publication-title: Leuk. Lymphoma
  doi: 10.1080/10428194.2019.1599110
– ident: 10.1016/j.semcdb.2023.10.007_bib11
  doi: 10.1038/s41467-019-09415-3
– volume: 31
  start-page: 1062
  issue: 5
  year: 2012
  ident: 10.1016/j.semcdb.2023.10.007_bib56
  article-title: A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
  publication-title: EMBO J.
  doi: 10.1038/emboj.2011.497
– volume: 20
  start-page: 4
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib7
  article-title: Realizing the clinical potential of immunogenic cell death in cancer chemotherapy and radiotherapy
  publication-title: Int J. Mol. Sci.
  doi: 10.3390/ijms20040959
– volume: 38
  start-page: 729
  issue: 4
  year: 2013
  ident: 10.1016/j.semcdb.2023.10.007_bib28
  article-title: Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.03.003
– year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib185
  article-title: Immunogenic cell death (ICD) enhancers-Drugs that enhance the perception of ICD by dendritic cells
  publication-title: Immunol. Rev.
– volume: 23
  start-page: 7
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib153
  article-title: Norcantharidin induces immunogenic cell death of bladder cancer cells through promoting autophagy in acidic culture
  publication-title: Int J. Mol. Sci.
– volume: 12
  start-page: 2121
  issue: 12
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib169
  article-title: Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids
  publication-title: Metallomics
  doi: 10.1039/d0mt00227e
– volume: 11
  start-page: 2093518
  issue: 1
  year: 2022
  ident: 10.1016/j.semcdb.2023.10.007_bib196
  article-title: PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2022.2093518
– volume: 273
  start-page: 33741
  issue: 50
  year: 1998
  ident: 10.1016/j.semcdb.2023.10.007_bib55
  article-title: Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.273.50.33741
– volume: 495
  start-page: 12
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib173
  article-title: CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2020.09.011
– volume: 9
  start-page: 1196
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib144
  article-title: Mitochondria-targeting immunogenic cell death inducer improves the adoptive t-cell therapy against solid tumor
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2019.01196
– volume: 12
  start-page: 42
  issue: 1
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib130
  article-title: The gold complex auranofin: new perspectives for cancer therapy
  publication-title: Discov. Oncol.
  doi: 10.1007/s12672-021-00439-0
– volume: 350
  start-page: 972
  issue: 6263
  year: 2015
  ident: 10.1016/j.semcdb.2023.10.007_bib19
  article-title: Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
  publication-title: Science
  doi: 10.1126/science.aad0779
– volume: 20
  start-page: e452
  issue: 8
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib100
  article-title: Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(19)30171-8
– volume: 20
  start-page: 51
  issue: 1
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib126
  article-title: Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis
  publication-title: Cell Mol. Immunol.
  doi: 10.1038/s41423-022-00956-0
– volume: 15
  start-page: 274
  issue: 2
  year: 2008
  ident: 10.1016/j.semcdb.2023.10.007_bib37
  article-title: Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4402275
– volume: 81
  start-page: 1375
  issue: 5
  year: 2021
  ident: 10.1016/j.semcdb.2023.10.007_bib150
  article-title: Enhanced antitumor immunity via endocrine therapy prevents mammary tumor relapse and increases immune checkpoint blockade sensitivity
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-20-1441
– volume: 11
  start-page: 7
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib127
  article-title: Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
  publication-title: J. Immunother. Cancer
  doi: 10.1136/jitc-2023-006785
– volume: 39
  start-page: 208
  issue: 3
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib157
  article-title: Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma
  publication-title: J. Recept Signal Transduct. Res
  doi: 10.1080/10799893.2019.1655050
– volume: 9
  start-page: 1721810
  issue: 1
  year: 2020
  ident: 10.1016/j.semcdb.2023.10.007_bib70
  article-title: PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2020.1721810
– volume: 9
  start-page: eadf2746
  issue: 26
  year: 2023
  ident: 10.1016/j.semcdb.2023.10.007_bib119
  article-title: A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.adf2746
– volume: 8
  issue: 11
  year: 2019
  ident: 10.1016/j.semcdb.2023.10.007_bib149
  article-title: Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2019.1656502
– volume: 7
  issue: 6
  year: 2016
  ident: 10.1016/j.semcdb.2023.10.007_bib162
  article-title: Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2016.134
SSID ssj0004926
Score 2.5192654
SecondaryResourceType review_article
Snippet The successful treatment of oncological malignancies which results in long-term disease control or the complete eradication of cancerous cells necessitates the...
SourceID hal
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 11
SubjectTerms Antigens, Neoplasm
Antineoplastic Agents - pharmacology
Cell Death
Humans
Life Sciences
Neoplasms - pathology
T-Lymphocytes
Title Immunogenic cell stress and death in the treatment of cancer
URI https://dx.doi.org/10.1016/j.semcdb.2023.10.007
https://www.ncbi.nlm.nih.gov/pubmed/37977108
https://www.proquest.com/docview/2891759234
https://hal.science/hal-04601413
Volume 156
WOSCitedRecordID wos001161963100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1096-3634
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004926
  issn: 1084-9521
  databaseCode: AIEXJ
  dateStart: 20201001
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdoB9NeEJ-jfEwG8YZSETuJHYmXCg11CE1IDKk8RY7jaEEsqdpmjP-eu9hOKqZq8MBLVPkrkn_X8-8ud2dCXuuYmyTUCZglYK5GxvBAYQXaONQqjHIOj6i7bEKcnsrFIv3sCiqsu-sERF3Lq6t0-V-hhjYAG1Nn_wHuflFogN8AOjwBdnj-FfAnmPHRQHel36Bb3qeDoIe8QMLnQxuHGHMMLUf0V9tU9QuWHQGzF4d366CQFEOMEWDrKjgNn6E6FTZvqz7Mp2ptELA7H62HurHOgJ-m-mPmt_a8cSOdI4JFGIllUzGnxipPMIcCnjjnpNeu8bZ-tIr1mtq2HgTMsr_QRT7FK92nXcyd2B4O-7y86FDjAmhr-FYOh1gfWui7RmSPiTiVY7I3OzlefBySZVOW-BzKLtDv-ksPyL5fZhddGZ1j3Owuo6QjJ2f3yF1nVdCZlYb75JapH5A79p7RXw_Juy2ZoIgltTJBQSZoJxO0qinIBO1lgjYltTLxiHz9cHz2fh64azMCHUVsEwhZhnFeKsOMkKHicQgHHhBx4GqRBv4u84jznOtUxyWTplQKWHzCCsyRVkwo_piM66Y2TwjNDYtEnjJtBNBmTGrWRZoDByxUaWDShHC_O5l2NeXxapMfmQ8e_J7Z7c1we7EVtndCgn7W0tZUuWG88BufOV5o-V4G8nPDzFeAU_8SLKU-n33KsA0DAkJgcJfhhLz0MGagWxEFVZumXWdMpsCuwQSKJuTQ4tuv5QXk6c6eZ-Rg-Js8J-PNqjUvyG19uanWqyMyEgt55ITzN7kfmq0
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunogenic+cell+stress+and+death+in+the+treatment+of+cancer&rft.jtitle=Seminars+in+cell+%26+developmental+biology&rft.au=Pan%2C+Hui&rft.au=Liu%2C+Peng&rft.au=Zhao%2C+Liwei&rft.au=Pan%2C+Yuhong&rft.date=2024-03-15&rft.eissn=1096-3634&rft.volume=156&rft.spage=11&rft_id=info:doi/10.1016%2Fj.semcdb.2023.10.007&rft_id=info%3Apmid%2F37977108&rft.externalDocID=37977108
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1084-9521&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1084-9521&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1084-9521&client=summon